Rank,Term name,P-value,Z-score,Combined score,Overlapping genes,Adjusted p-value,Old p-value,Old adjusted p-value,gene count
1,Cytoplasmic Ribosomal Proteins WP477,1.7273638995639269e-37,23.844789356984478,2018.4388130602176,"['RPL4', 'RPL5', 'RPL30', 'RPL3', 'RPL32', 'RPL34', 'RPLP1', 'RPLP0', 'RPL10A', 'RPL8', 'RPL9', 'RPL6', 'RPL7', 'RPS4X', 'RPS15', 'RPL7A', 'RPS14', 'RPS17', 'RPS16', 'RPL18A', 'RPS19', 'RPS18', 'RPL36', 'RPL35', 'RPLP2', 'RPL38', 'RPL37', 'RPL39', 'RPS10', 'RPS13', 'RPS12', 'RPS9', 'RPS7', 'RPL21', 'RPS8', 'RPL23', 'RPS5', 'RPL22', 'RPL13A', 'RPSA', 'RPS3A', 'RPL37A', 'RPL24', 'RPL27', 'RPL26', 'RPL29', 'RPL28', 'UBA52', 'RPL10', 'RPL12', 'RPL11', 'MRPL19', 'RPL36A', 'RPS15A', 'RPL14', 'RPS3', 'RPL13', 'RPS2', 'RPL15', 'RPS27A', 'RPL18', 'RPL17', 'RPL19', 'RPL41', 'RPL35A', 'RPL23A', 'RPS26', 'RPS25', 'RPS28', 'RPS27', 'RPS29', 'RPL27A', 'FAU', 'RPS21', 'RPS24', 'RPS23']",9.828700588518744e-35,0,0,76
2,Electron Transport Chain (OXPHOS system in mitochondria) WP111,7.103606518409353e-29,13.193337389717067,855.1177862193242,"['COX7B', 'NDUFA12', 'COX4I1', 'COX6A1', 'COX7C', 'ATP5IF1', 'UQCRFS1', 'COX8A', 'NDUFC2', 'SDHC', 'NDUFC1', 'COX6B1', 'COX7A2L', 'SCO1', 'NDUFS6', 'NDUFS5', 'NDUFS3', 'NDUFS1', 'UQCRC2', 'SLC25A5', 'SLC25A4', 'SLC25A6', 'NDUFB9', 'NDUFB8', 'NDUFB7', 'UQCRB', 'NDUFB10', 'NDUFB6', 'COX15', 'NDUFB5', 'NDUFB4', 'COX17', 'NDUFB3', 'ATP5MC2', 'NDUFB2', 'ATP5MC3', 'NDUFB1', 'COX7A2', 'UQCR11', 'UQCR10', 'COX5B', 'UQCRH', 'ATP5MC1', 'ATP5F1A', 'ATP5F1B', 'COX11', 'NDUFV3', 'NDUFV1', 'ATP5MG', 'ATP5MF', 'ATP5ME', 'NDUFA9', 'ATP5PF', 'NDUFA8', 'SURF1', 'NDUFA7', 'ATP5PD', 'NDUFA6', 'NDUFA5', 'ATP5PB', 'NDUFA4', 'NDUFA3', 'NDUFA1', 'COX6C', 'ATP5F1D', 'ATP5F1E', 'UQCRQ', 'NDUFAB1', 'ATP5PO']",2.020976054487461e-26,0,0,69
3,Oxidative phosphorylation WP623,3.117950575235936e-19,15.943270971635485,679.3737195639156,"['NDUFB9', 'NDUFB8', 'NDUFB7', 'NDUFA11', 'NDUFB10', 'NDUFB6', 'NDUFB5', 'NDUFB4', 'ATP5MC2', 'NDUFB2', 'ATP5MC3', 'NDUFB1', 'ATP5MC1', 'ATP5F1A', 'ATP5F1B', 'NDUFV3', 'NDUFV1', 'ATP5MG', 'ATP5MF', 'ATP5ME', 'NDUFA9', 'ATP5PF', 'NDUFA8', 'NDUFA7', 'NDUFA6', 'ATP5PD', 'ATP6AP1', 'NDUFA5', 'ATP5PB', 'NDUFA4', 'NDUFA3', 'ATP6AP2', 'NDUFC2', 'NDUFC1', 'ATP5F1D', 'ATP5F1E', 'NDUFS6', 'NDUFS5', 'NDUFAB1', 'NDUFS3', 'ATP5PO', 'NDUFS1']",5.913712924364159e-17,0,0,42
4,Mitochondrial complex I assembly model OXPHOS system WP4324,1.714695980245224e-12,7.950617283950617,215.39641663432423,"['NDUFB9', 'NDUFA13', 'NDUFB8', 'NDUFB7', 'DMAC1', 'NDUFB10', 'NDUFB6', 'NDUFA12', 'NDUFB11', 'NDUFB5', 'NDUFB4', 'NDUFB3', 'NDUFB2', 'NDUFB1', 'TMEM186', 'FOXRED1', 'NDUFV3', 'NDUFV1', 'NDUFA8', 'NDUFA7', 'TIMMDC1', 'NDUFA6', 'NDUFA5', 'NDUFA3', 'ACAD9', 'NDUFA1', 'NDUFC2', 'NDUFC1', 'NDUFS6', 'NDUFS5', 'NDUFAB1', 'NDUFS3', 'NDUFAF3', 'NDUFS1', 'TMEM126B']",2.439155031898831e-10,0,0,35
5,Nonalcoholic fatty liver disease WP4396,6.811201365855821e-12,3.4770728881798845,89.40407182165714,"['NDUFA13', 'COX7B', 'GSK3A', 'NDUFA11', 'NDUFA12', 'COX4I1', 'PRKAG1', 'COX6A1', 'COX7C', 'BBC3', 'LEPR', 'UQCRFS1', 'RAC1', 'COX8A', 'PRKAB2', 'NDUFC2', 'SDHC', 'TRAF2', 'NDUFC1', 'COX6B1', 'ERN1', 'COX7A2L', 'NDUFS6', 'DDIT3', 'NDUFS5', 'NDUFS3', 'NDUFS1', 'UQCRC2', 'ATF4', 'NDUFB9', 'NDUFB8', 'NDUFB7', 'UQCRB', 'NDUFB10', 'NDUFB6', 'NDUFB11', 'NDUFB5', 'NDUFB4', 'NDUFB3', 'NDUFB2', 'NDUFB1', 'COX7A2', 'UQCR11', 'UQCR10', 'ADIPOR1', 'COX5B', 'UQCRH', 'CDC42', 'NDUFV3', 'NDUFV1', 'NDUFA9', 'NDUFA8', 'XBP1', 'NDUFA7', 'NDUFA6', 'NDUFA5', 'NDUFA4', 'NDUFA3', 'NDUFA1', 'COX6C', 'EIF2S1', 'UQCRQ', 'NDUFAB1', 'CYCS', 'BAX']",7.751147154343924e-10,0,0,65
6,Mitochondrial CIV Assembly WP4922,4.166359452210247e-08,7.470365926814637,126.9486952029427,"['COX8A', 'COA3', 'COX7B', 'SURF1', 'COX16', 'PET100', 'COX15', 'NDUFA4', 'COX4I1', 'COX17', 'COX7A2', 'COX6A1', 'COX5B', 'COX6C', 'COX7C', 'PET117', 'COX6B1', 'TMEM177', 'SCO2', 'COX11', 'COX14', 'SMIM20']",3.9510975471793845e-06,0,0,22
7,Proteasome Degradation WP183,5.5356233131418155e-08,4.353694344163658,72.7479536415262,"['RPN2', 'PSMD13', 'PSMB10', 'PSMA7', 'PSMD8', 'PSMB6', 'UCHL1', 'PSMD7', 'PSMB5', 'PSMD4', 'PSMB2', 'UBB', 'PSMB3', 'PSMD2', 'UBC', 'UBE2B', 'H2AFZ', 'HLA-B', 'HLA-C', 'HLA-A', 'HLA-F', 'PSMB8', 'PSMA3', 'PSMC5', 'PSMA4', 'PSMA1', 'PSMC3', 'PSMA2', 'PSME3', 'PSMC1', 'PSME1', 'PSME2']",4.4996709502538475e-06,0,0,32
8,Translation Factors WP107,1.5914970867108236e-07,4.4807088012678635,70.1384190659084,"['EIF4A2', 'EIF4A1', 'EEF1B2', 'EIF4EBP1', 'EIF4H', 'EIF4EBP2', 'EIF4B', 'EIF5B', 'EIF2B4', 'EIF2B2', 'EIF1AX', 'EIF2AK1', 'EIF2AK2', 'EIF2S2', 'EEF2', 'EIF2S1', 'EIF1', 'EEF1G', 'EEF1A1', 'EIF5', 'EIF2S3', 'EIF6', 'EIF3I', 'EIF3J', 'ETF1', 'EIF3F', 'EIF3D', 'EIF3A', 'EIF4G1']",1.1319523029230733e-05,0,0,29
9,Pyrimidine metabolism WP4022,1.0250677700593466e-06,3.146783669780054,43.396512653981716,"['DTYMK', 'POLD4', 'ZNRD1', 'POLR2A', 'POLR2C', 'POLR2D', 'TWISTNB', 'POLD2', 'POLR2E', 'TK2', 'POLR2G', 'POLR2I', 'POLR2K', 'POLR2L', 'DUT', 'RRM1', 'POLR3GL', 'NME2', 'CTPS2', 'NME4', 'NME1', 'DHODH', 'POLE4', 'UCK2', 'POLR3A', 'RRM2B', 'POLR3C', 'POLR3D', 'POLR1C', 'POLE3', 'POLR1D', 'POLR1E', 'CMPK2', 'POLR3H', 'UMPS', 'DCTPP1', 'POLR3K']",6.48070623515298e-05,0,0,37
10,Photodynamic therapy-induced unfolded protein response WP3613,3.590805848643787e-05,5.648009577970668,57.80482974623649,"['XBP1', 'WARS', 'HSPA5', 'PDIA6', 'HSP90B1', 'BBC3', 'NARS', 'ERN1', 'DDIT3', 'DNAJB11', 'DNAJB9', 'TRIB3', 'CALR', 'EIF2A', 'ATF4']",0.0020431685278783146,0,0,15
11,nsp1 from SARS-CoV-2 inhibits translation initiation in the host cell WP5027,0.0002675167501250764,6.207025411061285,51.061029271419855,"['EIF5', 'EIF2S3', 'EIF1AX', 'EIF3I', 'EIF3J', 'EIF3F', 'EIF2S2', 'EIF2S1', 'EIF3D', 'EIF3A', 'EIF1']",0.013837911892833498,0,0,11
12,Mitochondrial complex III assembly WP4921,0.00036316379476158375,6.7698744769874475,53.621850958895465,"['UQCRB', 'UQCC3', 'UQCC2', 'UQCRQ', 'LYRM7', 'UQCRFS1', 'UQCR11', 'UQCR10', 'UQCRC2', 'UQCRH']",0.01722001660161176,0,0,10
13,Ciliary landscape WP4352,0.00047921654929646885,1.6894294111685415,12.912913765588128,"['MCM9', 'MYL6B', 'SMC4', 'HSPB11', 'PSMD8', 'EFTUD2', 'PSMD7', 'APMAP', 'ARHGDIA', 'TMED1', 'RAC1', 'BBS4', 'RAB2A', 'ZYG11B', 'EIF5B', 'NUDC', 'DYNLT1', 'EIPR1', 'DYNLL1', 'DYNLL2', 'AFG3L2', 'MYL6', 'IFT43', 'MSH2', 'TIPRL', 'CD2BP2', 'EXOC3', 'MCM4', 'MCM6', 'PAFAH1B1', 'DDX5', 'ECHS1', 'RALB', 'PSMD13', 'VPS4A', 'COPS7B', 'COPS7A', 'EXOSC7', 'PGRMC2', 'RMND5A', 'EXOSC9', 'TCTEX1D2', 'SNRPB2', 'DCAF11', 'NDUFA9', 'DYNC1H1', 'NDUFA5', 'H3F3A', 'COX6C', 'LSM4', 'AIMP1', 'COPS4', 'IFT20', 'COPS3', 'COPS6', 'IFT22', 'GID4', 'RAB14', 'MFAP1', 'CNOT1', 'VAPB', 'GID8', 'CALM1', 'COPS8', 'CALM2', 'CNOT9', 'CLUAP1']",0.020974939734591597,0,0,67
14,mRNA Processing WP411,0.0006941938082843247,1.8876472364844459,13.728404133544435,"['SF3B5', 'SF3B2', 'TMED10', 'SF3B3', 'DHX8', 'RNMT', 'DDX1', 'SRP54', 'CSTF2T', 'HNRNPR', 'SNU13', 'YBX1', 'EFTUD2', 'POLR2A', 'SNRPD1', 'SNRPB2', 'SNRPD3', 'TXNL4A', 'HNRNPA1', 'SF3B1', 'SF3A1', 'PRMT2', 'NCBP2', 'PRMT1', 'CPSF3', 'SUPT5H', 'CLK3', 'LSM2', 'PRPF4', 'HNRNPM', 'LSM7', 'PRPF6', 'HNRNPK', 'PHF5A', 'SNRPG', 'CD2BP2', 'SNRPE', 'SNRPA1', 'HNRNPH2', 'SNRPF', 'HNRNPC', 'DNAJC8', 'RBMX', 'SNRPB', 'SRSF9']",0.02821401977955577,0,0,45
15,Cytosolic DNA-sensing pathway WP4655,0.0007632790173288999,2.824490407673861,20.273872721706987,"['NLRX1', 'POLR3GL', 'TRADD', 'ADAR', 'ISG15', 'NFKBIA', 'POLR3A', 'POLR3C', 'POLR3D', 'POLR1C', 'POLR1D', 'POLR2E', 'TRIM25', 'POLR2F', 'POLR3H', 'FADD', 'POLR3K', 'POLR2K', 'POLR2L', 'NFKBIB']",0.028953717390676266,0,0,20
16,Base Excision Repair WP4752,0.0010310368113144693,3.387009877282251,23.2931117115095,"['MBD4', 'FEN1', 'PCNA', 'PARP1', 'MPG', 'APEX2', 'LIG3', 'POLE4', 'POLD4', 'NEIL2', 'NTHL1', 'APEX1', 'POLD2', 'POLE3', 'MUTYH']",0.03666624660237081,0,0,15
17,Cellular Proteostasis WP4918,0.0030197254308845303,16.90540137272456,98.09510227820373,"['VBP1', 'PFDN1', 'PFDN2', 'PFDN4', 'PFDN5']",0.0978998754450049,0,0,5
18,Eukaryotic Transcription Initiation WP405,0.003097008362056394,2.5405182744158177,14.67738367844112,"['GTF2A2', 'TAF12', 'TAF13', 'ILK', 'GTF2H3', 'POLR2A', 'POLR2C', 'POLR3D', 'POLR2E', 'POLR1D', 'POLR2F', 'POLR1E', 'TAF7', 'POLR2G', 'POLR3H', 'POLR2I', 'POLR3K', 'POLR2K']",0.0978998754450049,0,0,18
19,Glycolysis and Gluconeogenesis WP534,0.007231855921553606,2.7500560873466946,13.555740309807145,"['PDHA1', 'MDH2', 'PGAM1', 'GOT2', 'SLC2A3', 'ENO2', 'GCK', 'LDHA', 'MPC2', 'PGK1', 'ALDOA', 'PFKM', 'GAPDH']",0.21657505365073693,0,0,13
20,Endoplasmic reticulum stress response in coronavirus infection WP4861,0.010412894813645329,2.2137558458313173,10.105154232755593,"['MBTPS1', 'XBP1', 'PPP1R11', 'HSPA5', 'PPP1R10', 'EIF2AK1', 'EIF2AK2', 'EIF2S1', 'ERN1', 'PPP1R2', 'PPP1R3F', 'MAP1LC3A', 'PPP1R7', 'PPP1R3E', 'DDIT3', 'PPP1R8', 'ATF4']",0.28809486562183073,0,0,17
21,Methionine De Novo and Salvage Pathway WP3580,0.010632675181122049,3.3827308037048103,15.370531567714362,"['AHCY', 'ADI1', 'AMD1', 'ODC1', 'MSRB2', 'SMS', 'TXN', 'MAT2B', 'SRM']",0.28809486562183073,0,0,9
22,7q11.23 copy number variation syndrome WP4932,0.012517306606600288,1.7232487744223732,7.548937790740328,"['BECN1', 'PCNA', 'CLTC', 'ATP5MC2', 'ATP5MC3', 'DDX21', 'UBE2L6', 'FBLN5', 'ATP5MC1', 'ATP5F1A', 'ATP5F1B', 'NUP62', 'EIF4H', 'BUD23', 'SF3B1', 'EIF2A', 'MAPK3', 'ATP5PB', 'VPS37C', 'DEK', 'ATP5F1D', 'ATP5F1E', 'MYBBP1A', 'DNAJC30', 'ATP5PO', 'GRB2', 'SQSTM1', 'GAPDH', 'VAMP2', 'ATF4']",0.3237430663252529,0,0,30
23,Immune response to tuberculosis WP4197,0.01616714039450566,3.044188825814162,12.556592342611497,"['STAT1', 'IFNGR2', 'TAP1', 'IFIT1', 'PSMB8', 'IFIT3', 'PTPN2', 'IRF9', 'IFNAR1']",0.3999609949771183,0,0,9
24,Hijack of ubiquitination by SARS-CoV-2 WP4860,0.018570698150906992,5.634139062966279,22.458637847832893,"['ZYG11B', 'CUL2', 'ELOB', 'ELOC', 'RBX1']",0.4402803019944199,0,0,5
25,16p11.2 proximal deletion syndrome WP4949,0.0213435331482671,1.7701838365654747,6.809908694000392,"['CCT3', 'CCT2', 'PCNA', 'PRRT2', 'IGFBP3', 'QPRT', 'TRAF2', 'PPP2R5D', 'KIF22', 'SEZ6L2', 'CCT6A', 'PPP2CB', 'HIRIP3', 'TCP1', 'KCTD13', 'TMEM219', 'CCT8', 'ALDOA', 'CCT7', 'CDIPT', 'CCT5', 'CCT4', 'MAPK3']",0.4857788144545593,0,0,23
26,Proximal tubule transport WP4917,0.02860971420403539,2.0595842114849217,7.319780744258215,"['ATP6V1A', 'ABCC4', 'ATP6V1G1', 'SLC22A6', 'SLC1A1', 'SLC3A1', 'SLC3A2', 'ATP1A1', 'FXYD2', 'ATP6V1E1', 'ATP6V0C', 'ATP6V1D', 'ATP6V1C1', 'ATP6V1F']",0.6241130346305264,0,0,14
27,Parkin-Ubiquitin Proteasomal System pathway WP2359,0.03132635932886338,1.7339379090942333,6.005139158034075,"['HSPA9', 'HSPA8', 'HSPA5', 'PSMD13', 'HSPA4', 'UBE2L6', 'UBE2G2', 'UBE2J2', 'HSPA14', 'TUBA4A', 'PSMD8', 'TUBB8', 'PSMC5', 'TUBA1A', 'PSMD7', 'TUBB2A', 'PSMD4', 'PSMC3', 'PSMD2', 'PSMC1', 'STUB1']",0.6241130346305264,0,0,21
28,Synaptic Vesicle Pathway WP2267,0.03273798075063929,1.8558772667111072,6.345651525113291,"['NAPA', 'RAB3A', 'SLC32A1', 'STXBP1', 'CLTC', 'CLTA', 'PARK7', 'SYP', 'AP2B1', 'CPLX2', 'AP2A2', 'CPLX3', 'AP2S1', 'STX3', 'SLC25A4', 'AP2M1', 'VAMP2']",0.6241130346305264,0,0,17
29,Type II interferon signaling (IFNG) WP619,0.033036205062292545,2.5363758589781895,8.649425168532288,"['STAT1', 'IFNGR2', 'IFI6', 'HLA-B', 'TAP1', 'EIF2AK2', 'PTPN11', 'ISG15', 'IRF9']",0.6241130346305264,0,0,9
30,Unfolded protein response WP4925,0.033036205062292545,2.5363758589781895,8.649425168532288,"['ERN1', 'MBTPS1', 'XBP1', 'HSPA5', 'DDIT3', 'RTCB', 'EIF2S1', 'BBC3', 'ATF4']",0.6241130346305264,0,0,9
31,Purine metabolism WP4792,0.0340026433629988,4.225231274246494,14.286846384782843,"['PRPS1', 'DGUOK', 'ATIC', 'ITPA', 'APRT']",0.6241130346305264,0,0,5
32,Selenium Micronutrient Network WP15,0.03579390406332135,1.7917210023613999,5.966390942413642,"['GPX4', 'TXNRD2', 'TXNRD1', 'APOA1', 'TXN', 'KMO', 'SELENOK', 'SELENOH', 'SOD1', 'SELENOM', 'PRDX4', 'SELENOS', 'FLAD1', 'PRDX1', 'SELENOW', 'PNPO', 'SEPHS2', 'MSRB1']",0.6242462002216509,0,0,18
33,Biomarkers for pyrimidine metabolism disorders WP4584,0.03620408542586025,3.3805970149253732,11.218792829708947,"['RRM1', 'RRM2B', 'TK2', 'CKB', 'UMPS', 'DHODH']",0.6242462002216509,0,0,6
34,Glycosylation and related congenital defects WP4521,0.041253124194763055,2.254632396891811,7.187832182777612,"['DPM2', 'ALG8', 'DPM3', 'MPI', 'SRD5A3', 'ALG14', 'ALG3', 'ALG13', 'MAGT1', 'ALG11']",0.6903831666711817,0,0,10
35,Urea cycle and metabolism of amino groups WP497,0.051874261012916666,2.6294416243654823,7.780340400317989,"['ACY1', 'ODC1', 'SMS', 'PYCR1', 'PYCR3', 'CKB', 'SRM']",0.8275844364557441,0,0,7
36,Dual hijack model of Vif in HIV infection WP3300,0.05236035098841263,4.505966587112172,13.290824434636919,"['UBB', 'ELOB', 'ELOC', 'RBX1']",0.8275844364557441,0,0,4
37,Cori Cycle WP1946,0.05452564033304625,2.8973987206823026,8.42877690642577,"['LDHA', 'PGAM1', 'PGK1', 'TALDO1', 'ALDOA', 'GAPDH']",0.8385159283649546,0,0,6
38,Intraflagellar transport proteins binding to dynein WP4532,0.0684316584082986,1.9890299215920677,5.334418568807474,"['DYNC2LI1', 'DYNC1H1', 'IFT22', 'DYNC1LI2', 'IFT43', 'DYNLT1', 'TCTEX1D2', 'DYNLL1', 'DYNLL2', 'HSPB11']",0.9999902239788879,0,0,10
39,miR-517 relationship with ARCN1 and USP1 WP3596,0.08211718328217199,5.068147927229347,12.668383040439705,"['ID2', 'USP1', 'ARCN1']",0.9999902239788879,0,0,3
40,Somitogenesis in the context of spondylocostal dysostosis WP4785,0.08211718328217199,5.068147927229347,12.668383040439705,"['RIPPLY2', 'DLL1', 'DLL3']",0.9999902239788879,0,0,3
41,Computational Model of Aerobic Glycolysis WP4629,0.08300811895221849,2.8163234855267083,7.009313366298779,"['LDHA', 'PGK1', 'ALDOA', 'GAPDH', 'PFKM']",0.9999902239788879,0,0,5
42,Cysteine and methionine catabolism WP4504,0.08300811895221849,2.8163234855267083,7.009313366298779,"['AHCY', 'GSS', 'ETHE1', 'SUOX', 'CDO1']",0.9999902239788879,0,0,5
43,RalA downstream regulated genes WP2290,0.08300811895221849,2.8163234855267083,7.009313366298779,"['CDC42', 'RALBP1', 'RAC3', 'RAC1', 'HRAS']",0.9999902239788879,0,0,5
44,Heme Biosynthesis WP561,0.08615003616117294,3.3791766109785204,8.28460867540444,"['ALAD', 'FECH', 'UROD', 'UROS']",0.9999902239788879,0,0,4
45,Interleukin-1 Induced Activation of NF-kappa-B WP3656,0.08615003616117294,3.3791766109785204,8.28460867540444,"['UBE2N', 'UBE2V1', 'SQSTM1', 'PRKCZ']",0.9999902239788879,0,0,4
46,Mitochondrial CII Assembly WP4920,0.08615003616117294,3.3791766109785204,8.28460867540444,"['SDHAF3', 'SDHAF1', 'SDHAF4', 'SDHC']",0.9999902239788879,0,0,4
47,Metabolic reprogramming in colon cancer WP4290,0.0889333642755996,1.6908465450194436,4.091625287726365,"['PDHA1', 'MDH2', 'PGAM1', 'GOT2', 'IDH2', 'PYCR1', 'TALDO1', 'PYCR2', 'PDHB', 'LDHA', 'PGK1', 'TKT', 'GAPDH']",0.9999902239788879,0,0,13
48,DNA Repair Pathways Full Network WP4946,0.0937917182371389,1.345800898447839,3.1850783458061636,"['FEN1', 'DCLRE1C', 'PCNA', 'MPG', 'PRKDC', 'CETN2', 'POLD4', 'NTHL1', 'POLD2', 'USP1', 'MUTYH', 'MBD4', 'XRCC6', 'PARP1', 'CENPX', 'XRCC5', 'MGMT', 'RPA1', 'RPA2', 'APEX2', 'LIG3', 'RAD23A', 'GTF2H3', 'TERF2', 'GTF2H5', 'RBX1', 'FANCF', 'DDB1', 'POLE4', 'NEIL2', 'MSH2', 'APEX1', 'POLE3']",0.9999902239788879,0,0,33
49,Nucleotide metabolism WP404,0.09449711599119243,2.1509812969950324,5.074564883750469,"['PRPS1', 'RRM1', 'RRM2B', 'MTHFD2', 'NME2', 'OAZ1', 'SRM']",0.9999902239788879,0,0,7
50,Purine metabolism and related disorders WP4224,0.09449711599119243,2.1509812969950324,5.074564883750469,"['PRPS1', 'DGUOK', 'ATIC', 'RRM2B', 'PFAS', 'ITPA', 'APRT']",0.9999902239788879,0,0,7
51,Genotoxicity pathway WP4286,0.09830742465451225,1.5852757407961688,3.6772939464409893,"['PRKAB2', 'NLRX1', 'CEBPD', 'GADD45A', 'EI24', 'SEL1L', 'PCDH8', 'TRIAP1', 'TM7SF3', 'COIL', 'MEX3B', 'RPS27', 'RRM2B', 'BLOC1S2', 'ID2']",0.9999902239788879,0,0,15
52,p38 MAPK Signaling Pathway WP400,0.11222703059947249,1.6904334828101644,3.6973691940166438,"['CDC42', 'STAT1', 'TRADD', 'DDIT3', 'RASGRF1', 'TRAF2', 'GRB2', 'RAC1', 'HRAS', 'MEF2D', 'HMGN1']",0.9999902239788879,0,0,11
53,Parkinson's disease pathway WP2371,0.11222703059947249,1.6904334828101644,3.6973691940166438,"['CASP9', 'UCHL1', 'PINK1', 'UBB', 'CCNE2', 'SYT11', 'CYCS', 'UBE2L6', 'PARK7', 'UBE2G2', 'UBE2J2']",0.9999902239788879,0,0,11
54,Thiamine metabolic pathways WP4297,0.1278679736570908,2.7031026252983295,5.559625254904984,"['BCKDK', 'PDHA1', 'SLC25A19', 'TKT']",0.9999902239788879,0,0,4
55,TNF-alpha signaling pathway WP231,0.13094795802065523,1.3648838568067334,2.7747478729413917,"['HSP90AA1', 'CSNK2A1', 'TRADD', 'TRAF2', 'TXN', 'CFLAR', 'PRKCZ', 'CASP9', 'NFKBIA', 'PSMD2', 'CDC37', 'MADD', 'BAX', 'GRB2', 'RAC1', 'FADD', 'MAP2K7', 'NFKBIE', 'HRAS', 'BIRC2', 'SKP1', 'MAPK3', 'NFKBIB']",0.9999902239788879,0,0,23
56,Gastric acid production WP2596,0.1327573033068907,6.756112104949314,13.642161844530788,"['CCK', 'VIP']",0.9999902239788879,0,0,2
57,Secretion of Hydrochloric Acid in Parietal Cells WP2597,0.1327573033068907,6.756112104949314,13.642161844530788,"['CHRM1', 'CCKBR']",0.9999902239788879,0,0,2
58,DNA Replication WP466,0.13324959094745764,1.6167933970234614,3.258697674300621,"['POLD4', 'PCNA', 'ORC6', 'ORC3', 'UBC', 'POLD2', 'RPA1', 'RPA2', 'MCM4', 'MCM6', 'UBA52']",0.9999902239788879,0,0,11
59,DNA Mismatch Repair WP531,0.13359688920792806,1.8026284348864994,3.6285617955148233,"['POLE4', 'POLD4', 'PCNA', 'MSH2', 'POLD2', 'POLE3', 'RPA1', 'RPA2']",0.9999902239788879,0,0,8
60,Myometrial relaxation and contraction pathways WP289,0.1457503880304175,1.26416629727888,2.434607041640374,"['YWHAE', 'RGS17', 'CRCP', 'RGS14', 'YWHAB', 'RGS16', 'LPAR1', 'ATP2A2', 'ADCY3', 'PRKCZ', 'ACTG1', 'RGS4', 'RGS2', 'GNG3', 'YWHAQ', 'GNG4', 'PDE4B', 'NOS1', 'PRKACA', 'YWHAH', 'GSTO1', 'IGFBP3', 'CREB3', 'PRKAR1A', 'MAFF', 'GNB1', 'GNB4', 'CRH', 'CALM3', 'GNB5', 'ATF5', 'CALM1', 'CALM2', 'ATF4']",0.9999902239788879,0,0,34
61,Exercise-induced Circadian Regulation WP410,0.14688572154012325,1.4791479652902453,2.8371543024445693,"['DAZAP2', 'HSPA8', 'GSTM3', 'BTG1', 'GSTP1', 'G0S2', 'DNAJA1', 'PPP2CB', 'PSMA4', 'SUMO1', 'STBD1', 'KLF9', 'CRY2', 'EIF4G2']",0.9999902239788879,0,0,14
62,p53 transcriptional gene network WP4963,0.14990309914321087,1.4490101338350365,2.7498824545068925,"['PRKAB2', 'SIVA1', 'XRCC5', 'MGMT', 'GADD45A', 'FUCA1', 'ISG15', 'PML', 'BBC3', 'RRM2B', 'MSH2', 'SESN2', 'ULK2', 'BAX', 'IRF9']",0.9999902239788879,0,0,15
63,H19 action Rb-E2F1 signaling and CDK-Beta-catenin activity WP3969,0.15513582115342595,2.111869591166816,3.9353724289968115,"['JAG1', 'H2AFY', 'CCND1', 'CDH1', 'SOX4']",0.9999902239788879,0,0,5
64,Pyrimidine metabolism and related diseases WP4225,0.15513582115342595,2.111869591166816,3.9353724289968115,"['RRM1', 'RRM2B', 'TK2', 'UMPS', 'DHODH']",0.9999902239788879,0,0,5
65,G1 to S cell cycle control WP45,0.16983247153763037,1.4086351391798864,2.497429512850486,"['CDKN2D', 'CDKN1B', 'PCNA', 'GADD45A', 'RPA1', 'RPA2', 'CREB3', 'CCND2', 'ORC6', 'CCND1', 'CCNE2', 'ORC3', 'CCNG2', 'MCM4', 'MCM6']",0.9999902239788879,0,0,15
66,GABA receptor Signaling WP4159,0.17030698789663382,1.600930920069819,2.833892125504279,"['GABBR1', 'SLC32A1', 'GABRA6', 'GABRA3', 'AP2S1', 'AP2B1', 'SLC6A1', 'AP2A2', 'AP2M1']",0.9999902239788879,0,0,9
67,Inhibition of exosome biogenesis and secretion by Manumycin A in CRPC cells WP4301,0.1728378315178071,1.84314789687924,3.2354646090388814,"['RAB5B', 'RAB5C', 'MRAS', 'RAB27A', 'HRAS', 'MAPK3']",0.9999902239788879,0,0,6
68,Non-homologous end joining WP438,0.1761542743640755,2.2523866348448687,3.9110331363454254,"['XRCC6', 'DCLRE1C', 'PRKDC', 'XRCC5']",0.9999902239788879,0,0,4
69,IL-18 signaling pathway WP4754,0.17781816963751831,1.1856062277690007,2.0475345686584725,"['MTCH1', 'PIGT', 'TOMM40', 'CD83', 'ANP32A', 'CD81', 'HSPB8', 'RGS16', 'COX17', 'KLC1', 'RND2', 'ELAVL1', 'CENPB', 'RXRB', 'ADAMTS5', 'TMSB4X', 'STMN1', 'FADD', 'MAP2K7', 'B2M', 'ACADS', 'ABCF1', 'MAPK3', 'MBTPS1', 'PARP1', 'IMP3', 'ECH1', 'HPS1', 'NDUFC1', 'BPGM', 'DEK', 'CFLAR', 'EEF2', 'ARFGAP2', 'NFKBIA', 'ARL4D', 'BMP2', 'NACA', 'SYT10', 'RFX5', 'CLDN12', 'CYCS', 'BAX', 'HDGF', 'LTB', 'NFKBIE', 'AARS', 'ITM2C']",0.9999902239788879,0,0,48
70,Nucleotide Excision Repair WP4753,0.18739650311437453,1.417502146999508,2.3736478422806497,"['PCNA', 'CETN2', 'RPA1', 'RPA2', 'RAD23A', 'GTF2H3', 'GTF2H5', 'RBX1', 'POLE4', 'DDB1', 'POLD4', 'POLD2', 'POLE3']",0.9999902239788879,0,0,13
71,VEGFA-VEGFR2 Signaling Pathway WP3888,0.18757973351230295,1.1209078505366965,1.8758967664180264,"['YWHAE', 'RPL5', 'ARF4', 'FLT1', 'CLTC', 'SRP54', 'RPL10A', 'RPL7', 'ACTG1', 'TUBB8', 'PSMD4', 'RPL18A', 'CCND1', 'TMSB4X', 'RACK1', 'RPLP2', 'ELOC', 'RAC1', 'ATP6V1E1', 'ACP1', 'HRAS', 'EIF2A', 'HSP90AA1', 'SSR4', 'TRPC3', 'TPM3', 'IGFBP3', 'SSR3', 'SHROOM2', 'SARS', 'RPL13A', 'TMEM170A', 'PDIA6', 'RHOA', 'EPN1', 'ERN1', 'RCN1', 'NCL', 'FSCN1', 'TFAM', 'RPL27', 'RPL26', 'TKT', 'ATP6V0D1', 'ALDOA', 'GAPDH', 'CRK', 'PTMA', 'ATF4', 'ENG', 'NAPA', 'LRRC59', 'HDAC5', 'SET', 'HTRA1', 'TXN', 'PRKCZ', 'CAMKK2', 'CDC42', 'STIP1', 'LDHA', 'FXR2', 'DHX36', 'AP2S1', 'PGK1', 'DNAJB9', 'MYH11', 'FADD', 'MAP2K7', 'CCT7', 'ABCF2', 'TXNDC5', 'MAPK3', 'JAG1', 'SDF2L1', 'STAT1', 'IDH2', 'PTPN11', 'PTPN14', 'DNAJA1', 'NFKBIA', 'BMP2', 'TFCP2', 'CYCS', 'HYOU1', 'TPP1', 'GRB2', 'P4HB', 'EIF3F', 'CALR', 'GRSF1', 'EIF3D', 'EIF4G2', 'EIF4G1']",0.9999902239788879,0,0,94
72,Pathogenic Escherichia coli infection WP2272,0.1894801789560521,1.3918928433132678,2.315373180178334,"['ARPC4', 'ARPC5', 'TUBA4A', 'RHOA', 'ACTG1', 'TUBB8', 'CDC42', 'TUBA1A', 'TUBB2A', 'YWHAQ', 'ARPC2', 'CDH1', 'ARPC3', 'NCL']",0.9999902239788879,0,0,14
73,Deregulation of Rab and Rab Effector Genes in Bladder Cancer WP2291,0.19826613592195405,1.877051626380185,3.0373417602643653,"['RPH3A', 'MADD', 'RAB27A', 'GCC2', 'UNC13D']",0.9999902239788879,0,0,5
74,"Cerebral organic acidurias, including diseases WP4519",0.20029748027128477,2.533626603042052,4.073948991116067,"['GCDH', 'MDH2', 'IDH2']",0.9999902239788879,0,0,3
75,Methionine metabolism leading to sulfur amino acids and related disorders WP4292,0.20029748027128477,2.533626603042052,4.073948991116067,"['AHCY', 'MAT2B', 'CDO1']",0.9999902239788879,0,0,3
76,Pentose Phosphate Metabolism WP134,0.20029748027128477,2.533626603042052,4.073948991116067,"['TALDO1', 'PGLS', 'TKT']",0.9999902239788879,0,0,3
77,Acute viral myocarditis WP4298,0.21373601376113394,1.319117861837301,2.0354168087359197,"['DFFA', 'CXADR', 'PARP1', 'STAT1', 'ILK', 'CASP9', 'CCND1', 'SGCB', 'DAG1', 'RAC3', 'CYCS', 'BAX', 'NOS1', 'EIF4G2', 'MAPK3', 'EIF4G1']",0.9999902239788879,0,0,16
78,Gene regulatory network modelling somitogenesis  WP2854,0.2259921761873632,3.377757901013715,5.023586985746595,"['RIPPLY2', 'DLL1']",0.9999902239788879,0,0,2
79,Vitamin B6-dependent and responsive disorders WP4228,0.2259921761873632,3.377757901013715,5.023586985746595,"['PNPO', 'PIGV']",0.9999902239788879,0,0,2
80,Androgen receptor signaling pathway WP138,0.22973681951934602,1.2395620875824835,1.8231738106210063,"['UBE2I', 'DSTN', 'PARK7', 'RNF4', 'RHOA', 'RHOB', 'CDC42', 'PSMC3IP', 'CCND1', 'SUMO1', 'KAT5', 'ZMIZ1', 'PRDX1', 'BAG1', 'RACK1', 'KAT7', 'STUB1', 'RAC1', 'CALR', 'FKBP4', 'PATZ1', 'RAN']",0.9999902239788879,0,0,22
81,CAMKK2  Pathway WP4874,0.23116433863434435,1.4482052157582483,2.121079589795364,"['FIS1', 'MAP1LC3A', 'NOS1', 'RAC1', 'CALM1', 'SQSTM1', 'CALM2', 'CAMKK2', 'MAPK3']",0.9999902239788879,0,0,9
82,PDGF Pathway WP2526,0.2356517374091696,1.3767812655705032,1.9899999893086937,"['CDC42', 'NFKBIA', 'STAT1', 'PDGFA', 'ARFIP2', 'PTPN11', 'GRB2', 'RAC1', 'HRAS', 'RHOA', 'MAPK3']",0.9999902239788879,0,0,11
83,DNA damage response WP707,0.23689710120362564,1.2999332304929432,1.8720720688122838,"['CDKN1B', 'PRKDC', 'GADD45A', 'RPA2', 'PML', 'BBC3', 'CASP9', 'CCND2', 'CCND1', 'RRM2B', 'CCNE2', 'CYCS', 'RAD17', 'BAX', 'ATRIP']",0.9999902239788879,0,0,15
84,Photodynamic therapy-induced NF-kB survival signaling WP3617,0.2448585251318775,1.6891972545508804,2.3768266925971426,"['EGLN2', 'CCND1', 'CFLAR', 'BCL2L2', 'BIRC2']",0.9999902239788879,0,0,5
85,FBXL10 enhancement of MAP/ERK signaling in diffuse large B-cell lymphoma WP4553,0.25385808625636613,1.5593111366245695,2.137784200631578,"['H3F3B', 'H2AFY', 'H2AFJ', 'H2AFZ', 'H3F3A', 'MAPK3']",0.9999902239788879,0,0,6
86,Apoptosis WP254,0.2582576990076894,1.2490396760290114,1.6909466149434829,"['HRK', 'DFFA', 'TRADD', 'TRAF2', 'IGF1', 'CFLAR', 'BBC3', 'CASP9', 'NFKBIA', 'CYCS', 'BAX', 'FADD', 'NFKBIE', 'TNFRSF21', 'BIRC2', 'BCL2L2', 'NFKBIB']",0.9999902239788879,0,0,17
87,DNA IR-double strand breaks and cellular response via ATM WP3959,0.2626739729104449,1.278697009397189,1.7094154359150782,"['UPF1', 'DCLRE1C', 'PCNA', 'PARP1', 'PRKDC', 'RNF8', 'TERF2', 'CASP9', 'RASSF1', 'KAT5', 'HSF1', 'NABP2', 'RAD17', 'BAX']",0.9999902239788879,0,0,14
88,ATR Signaling WP3875,0.2687859458482058,2.0267223382045927,2.66278878864594,"['RPA1', 'HUS1', 'ATRIP']",0.9999902239788879,0,0,3
89,"Degradation pathway of sphingolipids, including diseases WP4153",0.2687859458482058,2.0267223382045927,2.66278878864594,"['NEU3', 'HEXB', 'NEU1']",0.9999902239788879,0,0,3
90,Leptin and adiponectin WP3934,0.2687859458482058,2.0267223382045927,2.66278878864594,"['PRKAG1', 'LEPR', 'ADIPOR1']",0.9999902239788879,0,0,3
91,Alzheimer's disease WP2059,0.2766684187190834,1.2115842384697588,1.5568076406380689,"['ATP5MD', 'MME', 'PSEN2', 'ATP2A2', 'ATP2A1', 'HSD17B10', 'CASP9', 'ERN1', 'BACE1', 'CHP1', 'CYCS', 'CALM3', 'NOS1', 'MAPT', 'FADD', 'CALM1', 'GAPDH', 'CALM2', 'MAPK3']",0.9999902239788879,0,0,19
92,Cell Differentiation - Index expanded WP2023,0.2858511808377292,1.688991646778043,2.1150971314692315,"['SOX2', 'HDAC5', 'ID2', 'MEF2D']",0.9999902239788879,0,0,4
93,NO metabolism in cystic fibrosis WP4947,0.2858511808377292,1.688991646778043,2.1150971314692315,"['PRMT5', 'PRMT2', 'PRMT1', 'NOS1']",0.9999902239788879,0,0,4
94,miRNA regulation of DNA damage response WP1530,0.2866740612211265,1.2363028449200983,1.5446483756345584,"['CDKN1B', 'PRKDC', 'GADD45A', 'RPA2', 'PML', 'BBC3', 'CASP9', 'CCND2', 'CCND1', 'RRM2B', 'CCNE2', 'CYCS', 'RAD17', 'BAX', 'ATRIP']",0.9999902239788879,0,0,15
95,Canonical and non-canonical Notch signaling WP3845,0.2976827668557268,1.4478038379530918,1.7543428567406043,"['JAG1', 'MFAP1', 'PSEN2', 'DLL1', 'DLL3', 'DLK2']",0.9999902239788879,0,0,6
96,Arachidonate Epoxygenase / Epoxide Hydrolase WP678,0.32190882241166274,2.2516398330351817,2.552204330250508,"['COX8A', 'GSTP1']",0.9999902239788879,0,0,2
97,Mitochondrial fatty acid synthesis pathway WP4317,0.32190882241166274,2.2516398330351817,2.552204330250508,"['MECR', 'HSD17B12']",0.9999902239788879,0,0,2
98,"Phase I biotransformations, non P450 WP136",0.32190882241166274,2.2516398330351817,2.552204330250508,"['ESD', 'CES2']",0.9999902239788879,0,0,2
99,Osteoclast Signaling WP12,0.33924491849374866,1.688786161646287,1.8256335014884972,"['AIMP2', 'ATP6V1G1', 'IFNAR1']",0.9999902239788879,0,0,3
100,Vitamin B12 Disorders WP4271,0.33924491849374866,1.688786161646287,1.8256335014884972,"['MMAB', 'MMACHC', 'CD320']",0.9999902239788879,0,0,3
101,Gastric Cancer Network 2 WP2363,0.34025504871634144,1.3136757240967454,1.4162209874721383,"['OTUD5', 'DSCC1', 'UBE2T', 'RAD17', 'BRIX1', 'CACYBP', 'CEBPZ']",0.9999902239788879,0,0,7
102,Intracellular trafficking proteins involved in CMT neuropathy WP4856,0.34025504871634144,1.3136757240967454,1.4162209874721383,"['RAB3B', 'RAB3A', 'RAB4B', 'SH3TC2', 'HSPB8', 'MPZ', 'MFN2']",0.9999902239788879,0,0,7
103,NOTCH1 regulation of endothelial cell calcification WP3413,0.3439468846505427,1.5011933174224343,1.6021756474689821,"['JAG1', 'LPAR1', 'DLL1', 'DLL3']",0.9999902239788879,0,0,4
104,Omega-3/Omega-6 FA synthesis WP4723,0.3439468846505427,1.5011933174224343,1.6021756474689821,"['ACOX1', 'ACOT2', 'ACOX3', 'PLA2G6']",0.9999902239788879,0,0,4
105,Nanomaterial induced apoptosis WP2507,0.3443178585541206,1.4074156968069234,1.5005725992237129,"['CASP9', 'BAX', 'CYCS', 'CFLAR', 'FADD']",0.9999902239788879,0,0,5
106,Target Of Rapamycin (TOR) Signaling WP1471,0.36990784613718974,1.216062145204661,1.209375468024451,"['CDC42', 'PRKAB2', 'RRAGA', 'RRAGC', 'RRAGD', 'PRKAG1', 'EIF4EBP1', 'ULK2', 'RAC1']",0.9999902239788879,0,0,9
107,Trans-sulfuration and one-carbon metabolism WP2525,0.3819560358165644,1.244424887240496,1.1976964421318645,"['AHCY', 'MTHFD1', 'MTHFD2', 'GSS', 'MTHFD2L', 'AMT', 'MAT2B']",0.9999902239788879,0,0,7
108,Senescence and Autophagy in Cancer WP615,0.3878228033186331,1.1076384793804301,1.0491626288907272,"['GABARAPL2', 'BECN1', 'GABARAPL1', 'SPARC', 'CDKN1B', 'PCNA', 'IGFBP3', 'IGF1', 'CXCL14', 'GABARAP', 'RSL1D1', 'BMP2', 'MAP1LC3B', 'ING2', 'MAP1LC3A', 'ATG16L1', 'CREG1', 'SLC39A1', 'SQSTM1', 'HRAS']",0.9999902239788879,0,0,20
109,SARS-CoV-2 mitochondrial interactions WP5038,0.38842855742196364,1.2666044776119403,1.1977594824898397,"['TOMM70', 'NDUFB9', 'NLRX1', 'CTSL', 'ACAD9', 'PHB']",0.9999902239788879,0,0,6
110,Extracellular vesicles in the crosstalk of cardiac cells WP4300,0.4022191660277285,1.3509546539379476,1.2303929610855888,"['CD63', 'CD81', 'IGF1', 'SOD1']",0.9999902239788879,0,0,4
111,TP53 network WP1742,0.4022191660277285,1.3509546539379476,1.2303929610855888,"['SUMO1', 'GADD45A', 'BAX', 'BBC3']",0.9999902239788879,0,0,4
112,Aflatoxin B1 metabolism WP699,0.40480150785392244,3.377049180327869,3.054062915287367,['AKR7A2'],0.9999902239788879,0,0,1
113,Arylamine metabolism WP694,0.40480150785392244,3.377049180327869,3.054062915287367,['SULT1A1'],0.9999902239788879,0,0,1
114,Fas ligand pathway and stress induction of heat shock proteins WP314,0.4062337971095155,1.1691871021121096,1.0532346433984405,"['CASP9', 'DFFA', 'PARP1', 'PRKDC', 'CYCS', 'FADD', 'CFLAR', 'SPTAN1', 'ACTG1']",0.9999902239788879,0,0,9
115,Dopamine metabolism WP2436,0.4091408854995853,1.447403178390354,1.2935380240917393,"['PPP2CB', 'PRKACA', 'SOD1']",0.9999902239788879,0,0,3
116,Iron metabolism in placenta WP2007,0.4091408854995853,1.447403178390354,1.2935380240917393,"['TFR2', 'FTH1', 'MCOLN1']",0.9999902239788879,0,0,3
117,Nanoparticle triggered regulated necrosis WP2513,0.4091408854995853,1.447403178390354,1.2935380240917393,"['PARP1', 'TRADD', 'FADD']",0.9999902239788879,0,0,3
118,Methylation Pathways WP704,0.4144152770184484,1.6885807990459154,1.4874484071399978,"['MAT2B', 'HNMT']",0.9999902239788879,0,0,2
119,miRNA Biogenesis WP2338,0.4144152770184484,1.6885807990459154,1.4874484071399978,"['XPO5', 'RAN']",0.9999902239788879,0,0,2
120,Molybdenum cofactor (Moco) biosynthesis WP4507,0.4144152770184484,1.6885807990459154,1.4874484071399978,"['SUOX', 'MOCS1']",0.9999902239788879,0,0,2
121,Peroxiredoxin 2 induced ovarian failure WP4873,0.4144152770184484,1.6885807990459154,1.4874484071399978,"['STAR', 'BAX']",0.9999902239788879,0,0,2
122,Pilocytic astrocytoma WP2253,0.4144152770184484,1.6885807990459154,1.4874484071399978,"['PTPN11', 'GRB2']",0.9999902239788879,0,0,2
123,Photodynamic therapy-induced HIF-1 survival signaling WP3614,0.4146025375659421,1.1747961144875592,1.0343315682850407,"['LDHA', 'PDHA1', 'SLC16A1', 'IGFBP3', 'PGK1', 'BAX', 'SLC2A3', 'HIF1AN']",0.9999902239788879,0,0,8
124,Calcium Regulation in the Cardiac Cell WP536,0.43269367134108067,1.0556035778713169,0.8843057794408292,"['YWHAE', 'RGS17', 'CHRM1', 'RGS14', 'YWHAB', 'RGS16', 'ATP2A2', 'ADCY3', 'PRKCZ', 'GNAI2', 'RGS4', 'RGS2', 'GNG3', 'YWHAQ', 'GNG4', 'PRKACA', 'YWHAH', 'KCNB1', 'ATP2B3', 'ATP1B2', 'GNAO1', 'PRKAR1A', 'FXYD2', 'GNB1', 'GNB4', 'CALM3', 'CALR', 'GNB5', 'CALM1', 'CALM2']",0.9999902239788879,0,0,30
125,16p11.2 distal deletion syndrome WP4950,0.43401906191174616,1.1919929762949957,0.9949169922200615,"['CD81', 'PRMT1', 'ATP2A1', 'TRAF2', 'GRB2', 'SH2B1']",0.9999902239788879,0,0,6
126,Fluoropyrimidine Activity WP1601,0.43401906191174616,1.1919929762949957,0.9949169922200615,"['ABCC4', 'RRM1', 'UCK2', 'GGH', 'UMPS', 'CES2']",0.9999902239788879,0,0,6
127,Hereditary leiomyomatosis and renal cell carcinoma pathway WP4206,0.44568761849544886,1.2061431555612396,0.9747288863657666,"['LDHA', 'PDHA1', 'PRKAG1', 'KEAP1', 'PDHB']",0.9999902239788879,0,0,5
128,Host-pathogen interaction of human coronaviruses - autophagy WP4863,0.44568761849544886,1.2061431555612396,0.9747288863657666,"['BECN1', 'MAP1LC3A', 'ATG16L1', 'ULK2', 'WIPI1']",0.9999902239788879,0,0,5
129,RAC1/PAK1/p38/MMP2 Pathway WP3303,0.4579996359672576,1.0746014906697132,0.839142215715608,"['PTPN11', 'CASP9', 'NFKBIA', 'MSH2', 'TNIP1', 'STMN1', 'EIF4EBP1', 'BAX', 'GRB2', 'NOS1', 'RAC1', 'HRAS', 'CRK', 'MAPK3']",0.9999902239788879,0,0,14
130,Overview of interferons-mediated signaling pathway WP4558,0.45944119354434293,1.2280321110870036,0.955095004830966,"['STAT1', 'IFNGR2', 'IRF9', 'IFNAR1']",0.9999902239788879,0,0,4
131,Nucleotide-binding Oligomerization Domain (NOD) pathway WP1433,0.46527708822906527,1.1257091669154973,0.8613050318001825,"['CASP9', 'NFKBIA', 'NDUFA13', 'HSP90AA1', 'COPS6', 'RAC1', 'AAMP']",0.9999902239788879,0,0,7
132,Renin-angiotensin-aldosterone system (RAAS) WP4756,0.46527708822906527,1.1257091669154973,0.8613050318001825,"['CREB3', 'STAR', 'CALM3', 'CALM1', 'CALM2', 'CAMK1G', 'ATF4']",0.9999902239788879,0,0,7
133,Cancer immunotherapy by PD-1 blockade WP4585,0.4765509415186873,1.2663659409484045,0.9386059361924519,"['PTPN11', 'HLA-A', 'PDCD1LG2']",0.9999902239788879,0,0,3
134,Glycolysis in senescence WP5049,0.4765509415186873,1.2663659409484045,0.9386059361924519,"['LDHA', 'PGK1', 'GAPDH']",0.9999902239788879,0,0,3
135,Homologous recombination WP186,0.4765509415186873,1.2663659409484045,0.9386059361924519,"['POLD4', 'POLD2', 'RPA1']",0.9999902239788879,0,0,3
136,Mammary gland development pathway - Embryonic development (Stage 1 of 4) WP2813,0.4765509415186873,1.2663659409484045,0.9386059361924519,"['SFRP1', 'CCND1', 'CDH1']",0.9999902239788879,0,0,3
137,RAS and bradykinin pathways in COVID-19 WP4969,0.4765509415186873,1.2663659409484045,0.9386059361924519,"['SERPING1', 'NOS1', 'RHOA']",0.9999902239788879,0,0,3
138,Hair Follicle Development: Organogenesis - Part 2 of 3 WP2839,0.47896531012906335,1.1256716417910448,0.8286374075684335,"['CCND2', 'CCND1', 'CDH1', 'PDGFA', 'FGF1', 'GTPBP4']",0.9999902239788879,0,0,6
139,Oxidative Damage WP3941,0.491485219861452,1.080621266427718,0.7675905843349907,"['CDC42', 'CASP9', 'PCNA', 'CDKN1B', 'GADD45A', 'CYCS', 'TRAF2', 'NFKBIE']",0.9999902239788879,0,0,8
140,Apoptosis Modulation and Signaling WP1772,0.49393769453677433,1.039060340856748,0.732896945216165,"['HRK', 'DFFA', 'TRADD', 'CFLAR', 'BBC3', 'CASP9', 'NFKBIA', 'TOLLIP', 'PEA15', 'MADD', 'CYCS', 'BAX', 'FADD', 'BIRC2', 'BCL2L2', 'MAPK3']",0.9999902239788879,0,0,16
141,miRNA regulation of p53 pathway in prostate cancer WP3982,0.49502254616526914,1.1256341390629663,0.7914918619785054,"['CASP9', 'EI24', 'SHISA5', 'BAX', 'BBC3']",0.9999902239788879,0,0,5
142,NAD Metabolism in Oncogene-Induced Senescence and Mitochondrial Dysfunction-Associated Senescence WP5046,0.49502254616526914,1.1256341390629663,0.7914918619785054,"['PARP1', 'MDH2', 'SCO2', 'GOT2', 'ELAVL1']",0.9999902239788879,0,0,5
143,Striated Muscle Contraction Pathway WP383,0.49502254616526914,1.1256341390629663,0.7914918619785054,"['TPM4', 'TPM3', 'TPM1', 'ACTG1', 'TTN']",0.9999902239788879,0,0,5
144,3q29 copy number variation syndrome WP4906,0.4969928909701002,1.045233109696167,0.7308056224641671,"['DYNLT1', 'NCBP2', 'RNF8', 'PIGZ', 'MAD2L1BP', 'WDR53', 'FBXO45', 'DYNLL1', 'DYNLL2', 'PIGX', 'DYNC2LI1', 'TCTEX1D2', 'UBE2N']",0.9999902239788879,0,0,13
145,Estrogen metabolism WP697,0.5000623499479372,1.3507453786523553,0.9360969235604006,"['SULT1A1', 'ARSD']",0.9999902239788879,0,0,2
146,Mammary gland development pathway - Involution (Stage 4 of 4) WP2815,0.5000623499479372,1.3507453786523553,0.9360969235604006,"['CDH1', 'BAX']",0.9999902239788879,0,0,2
147,NAD Biosynthesis II (from tryptophan) WP2485,0.5000623499479372,1.3507453786523553,0.9360969235604006,"['QPRT', 'KMO']",0.9999902239788879,0,0,2
148,Serotonin Transporter Activity WP1455,0.5000623499479372,1.3507453786523553,0.9360969235604006,"['PPP2CB', 'NOS1']",0.9999902239788879,0,0,2
149,Sulfation Biotransformation Reaction WP692,0.5000623499479372,1.3507453786523553,0.9360969235604006,"['SULT1A1', 'SULT4A1']",0.9999902239788879,0,0,2
150,Type III interferon signaling WP2113,0.5000623499479372,1.3507453786523553,0.9360969235604006,"['STAT1', 'IRF9']",0.9999902239788879,0,0,2
151,Autophagy WP4923,0.5060217388263386,1.0744455604115204,0.7318861514021452,"['BECN1', 'MAP1LC3B', 'PRKAB2', 'ATG16L1', 'ATG9A', 'PRKAG1', 'WIPI2']",0.9999902239788879,0,0,7
152,Kynurenine Pathway and links to Cellular Senescence WP5044,0.5146273751457441,1.1255966587112172,0.7477475742109748,"['EIF2AK1', 'QPRT', 'NOS1', 'KMO']",0.9999902239788879,0,0,4
153,Pregnane X receptor pathway WP2876,0.5146273751457441,1.1255966587112172,0.7477475742109748,"['ABCC4', 'HSP90AA1', 'PSMC5', 'DNAJC7']",0.9999902239788879,0,0,4
154,Aryl Hydrocarbon Receptor Pathway WP2873,0.5227685287070822,1.066331500392773,0.6916402020207039,"['HSP90AA1', 'CDKN1B', 'PTGES3', 'CDC37', 'AIP', 'BAX']",0.9999902239788879,0,0,6
155,BMP2-WNT4-FOXO1 pathway in primary endometrial stromal cell differentiation WP3876,0.54011749120538,1.1255592007157769,0.6933091102064562,"['SFRP1', 'BMP2', 'SST']",0.9999902239788879,0,0,3
156,Genes targeted by miRNAs in adipocytes WP1992,0.54011749120538,1.1255592007157769,0.6933091102064562,"['TMSB4X', 'IGF1', 'KCNJ2']",0.9999902239788879,0,0,3
157,Control of immune tolerance by vasoactive intestinal peptide WP4484,0.5408235000294888,1.6883755588673621,1.0377808059671763,['VIP'],0.9999902239788879,0,0,1
158,GABA metabolism (aka GHB) WP4157,0.5408235000294888,1.6883755588673621,1.0377808059671763,['AKR7A2'],0.9999902239788879,0,0,1
159,let-7 inhibition of ES cell reprogramming WP3299,0.5408235000294888,1.6883755588673621,1.0377808059671763,['SOX2'],0.9999902239788879,0,0,1
160,Nanomaterial-induced inflammasome activation WP3890,0.5408235000294888,1.6883755588673621,1.0377808059671763,['CTSB'],0.9999902239788879,0,0,1
161,Steroid Biosynthesis WP496,0.5408235000294888,1.6883755588673621,1.0377808059671763,['HSD17B1'],0.9999902239788879,0,0,1
162,Fatty Acid Biosynthesis WP357,0.5426016363109658,1.055188749626977,0.6451211532666229,"['MECR', 'ECHS1', 'ECH1', 'ECHDC1', 'ECHDC2']",0.9999902239788879,0,0,5
163,Leptin signaling pathway WP2034,0.5460555680944363,1.0003992015968064,0.6052760661016603,"['KHDRBS1', 'GSK3A', 'STAT1', 'PTPN11', 'RHOA', 'CDC42', 'CCND1', 'CFL2', 'LEPR', 'EIF4EBP1', 'BAX', 'GRB2', 'RAC1', 'HRAS', 'MAPK3', 'SH2B1']",0.9999902239788879,0,0,16
164,Sudden Infant Death Syndrome (SIDS) Susceptibility Pathways WP706,0.56112395999639,0.9862401727570267,0.5698628222591595,"['YWHAE', 'ADCYAP1R1', 'VIPR2', 'CHRNA4', 'YWHAB', 'ATP1A3', 'YBX1', 'ASCL1', 'HSP90B1', 'HSPD1', 'SOX2', 'MECP2', 'YWHAQ', 'TPPP', 'PRKACA', 'SCN3B', 'YWHAH', 'MBD1', 'SSTR2', 'GCK', 'PRKAR1A', 'SST', 'ALDOA', 'GAPDH', 'SLC25A4', 'VAMP2']",0.9999902239788879,0,0,26
165,Endothelin Pathways WP2197,0.5650122521873665,1.0129253731343284,0.5782870599352422,"['EDNRA', 'RIIAD1', 'ATP2A2', 'GNB5', 'CALM1', 'CALM2']",0.9999902239788879,0,0,6
166,One-carbon metabolism WP241,0.5650122521873665,1.0129253731343284,0.5782870599352422,"['AHCY', 'ATIC', 'MTHFD1', 'MTHFD2', 'AMT', 'MAT2B']",0.9999902239788879,0,0,6
167,Oxysterols derived from cholesterol WP4545,0.5650122521873665,1.0129253731343284,0.5782870599352422,"['DBP', 'NR1H2', 'ACOT2', 'ACOT13', 'SLC27A2', 'SLC27A5']",0.9999902239788879,0,0,6
168,Tryptophan metabolism WP465,0.5650122521873665,1.0129253731343284,0.5782870599352422,"['ALDH3A2', 'GCDH', 'ECHS1', 'WARS', 'PRMT1', 'HSD17B10']",0.9999902239788879,0,0,6
169,Bile acids synthesis and enterohepatic circulation  WP4389,0.5771544311420422,1.1255217650566487,0.6186378645048943,"['ABCG8', 'MAPK3']",0.9999902239788879,0,0,2
170,Caloric restriction and aging WP4191,0.5771544311420422,1.1255217650566487,0.6186378645048943,"['PRKAB2', 'IGF1']",0.9999902239788879,0,0,2
171,Canonical NF-KB pathway WP4562,0.5771544311420422,1.1255217650566487,0.6186378645048943,"['NFKBIA', 'NFKBIE']",0.9999902239788879,0,0,2
172,Cell Differentiation - Index WP2029,0.5771544311420422,1.1255217650566487,0.6186378645048943,"['HDAC5', 'MEF2D']",0.9999902239788879,0,0,2
173,HIF1A and PPARG regulation of glycolysis WP2456,0.5771544311420422,1.1255217650566487,0.6186378645048943,"['LDHA', 'GAPDH']",0.9999902239788879,0,0,2
174,IL-10 Anti-inflammatory Signaling Pathway  WP4495,0.5771544311420422,1.1255217650566487,0.6186378645048943,"['STAT1', 'BLVRB']",0.9999902239788879,0,0,2
175,SRF and miRs in Smooth Muscle Differentiation and Proliferation WP1991,0.5771544311420422,1.1255217650566487,0.6186378645048943,"['CCND2', 'MEF2D']",0.9999902239788879,0,0,2
176,Ebola Virus Pathway on Host WP4217,0.5771557796088869,0.9772124522463929,0.5371180492865661,"['STAT1', 'VPS33A', 'CLTC', 'VPS4A', 'HLA-B', 'HLA-C', 'EIF2AK2', 'CLTA', 'HLA-A', 'HLA-F', 'EIF2S1', 'ASGR1', 'RHOA', 'ACTG1', 'RHOB', 'CDC42', 'CTSL', 'VPS41', 'RAC1', 'CLEC4G', 'CTSB', 'MAPK3']",0.9999902239788879,0,0,22
177,Interferon type I signaling pathways WP585,0.5821742861820564,0.9772873888757769,0.5286982239249497,"['EIF4A1', 'PRMT1', 'STAT1', 'RACK1', 'EIF4EBP1', 'PTPN11', 'RAC1', 'CRK', 'IRF9', 'EIF4B', 'IFNAR1']",0.9999902239788879,0,0,11
178,Regulation of Microtubule Cytoskeleton WP2038,0.5824102137416491,0.9801748315776285,0.5298631505209181,"['CDC42', 'PTPRA', 'CFL2', 'DPYSL2', 'STMN1', 'TPPP', 'RAC1', 'MAPT', 'PRKACA']",0.9999902239788879,0,0,9
179,Alpha 6 Beta 4 signaling pathway WP244,0.5838821975685233,0.9847342490295611,0.5298422035858489,"['EIF4EBP1', 'PTPN11', 'GRB2', 'RAC1', 'HRAS', 'RHOA', 'MAPK3']",0.9999902239788879,0,0,7
180,7-oxo-C and 7beta-HC pathways WP5064,0.5879466303780879,0.9930310530658101,0.5274177590432865,"['DBP', 'ACOT2', 'ACOT13', 'SLC27A2', 'SLC27A5']",0.9999902239788879,0,0,5
181,Nanoparticle triggered autophagic cell death WP2509,0.5879466303780879,0.9930310530658101,0.5274177590432865,"['BECN1', 'MAP1LC3A', 'ATG16L1', 'ATG9B', 'ULK2']",0.9999902239788879,0,0,5
182,Retinoblastoma gene in cancer WP2446,0.5963096071527401,0.9644995722840034,0.49864171843596244,"['RRM1', 'CDKN1B', 'PCNA', 'PRMT2', 'H2AFZ', 'PRKDC', 'HMGB2', 'RPA1', 'RPA2', 'RABIF', 'CCND1', 'CCNE2', 'RBBP4', 'STMN1', 'MCM4', 'MCM6']",0.9999902239788879,0,0,16
183,Copper homeostasis WP3286,0.5977491084034305,0.9645632311502007,0.4963489641508757,"['BACE1', 'CCS', 'CCND1', 'SCO1', 'SCO2', 'COX17', 'COX11', 'MAPT', 'ATOX1', 'SOD1']",0.9999902239788879,0,0,10
184,Airway smooth muscle cell contraction WP4962,0.5989686311752654,1.012913808529675,0.5191649724575053,"['CALM1', 'CALM2', 'RHOA']",0.9999902239788879,0,0,3
185,Ferroptosis WP4313,0.6002860893573302,0.9645844000682711,0.4922746085704311,"['MAP1LC3B', 'MAP1LC3A', 'GPX4', 'FTH1', 'GSS', 'LPCAT3', 'VDAC2', 'SLC3A2']",0.9999902239788879,0,0,8
186,Folate Metabolism WP176,0.6002860893573302,0.9645844000682711,0.4922746085704311,"['AHCY', 'GPX4', 'MTHFD1', 'FLAD1', 'MTHFD2', 'APOA1', 'NOS1', 'SOD1']",0.9999902239788879,0,0,8
187,Glycogen Synthesis and Degradation WP500,0.6002860893573302,0.9645844000682711,0.4922746085704311,"['PPP2CB', 'GSK3A', 'PHKG2', 'PPP2R5B', 'PPP2R5D', 'CALM3', 'CALM1', 'CALM2']",0.9999902239788879,0,0,8
188,Pre-implantation embryo WP3527,0.60536318849829,0.9646055437100213,0.48416126722654496,"['SOX2', 'CDH1', 'DDIT3', 'SOX11', 'ATP1A1', 'ELAVL1']",0.9999902239788879,0,0,6
189,NRF2 pathway WP2884,0.6085536235803899,0.9578872725799262,0.4757541075324315,"['GSTM3', 'ABCC4', 'HSP90AA1', 'HSP90AB1', 'MGST3', 'GSTP1', 'TXNRD1', 'KEAP1', 'SLC2A3', 'TXN', 'SLC6A1', 'CES4A', 'SLC39A9', 'FTH1', 'PRDX1', 'MAFF', 'BLVRB', 'SLC39A7', 'SLC39A1', 'SQSTM1', 'CES2']",0.9999902239788879,0,0,21
190,Histone Modifications WP2369,0.614863218933905,0.9494603376157753,0.46177520420350376,"['SET', 'H3F3B', 'SETD9', 'SMYD5', 'EHMT2', 'H3F3A', 'SMYD2', 'KMT5B', 'HIST1H4C']",0.9999902239788879,0,0,9
191,TCA Cycle (aka Krebs or citric acid cycle) WP78,0.6161228334515509,0.9646266621206956,0.4671773069412659,"['MDH2', 'IDH2', 'IDH3B', 'SDHC']",0.9999902239788879,0,0,4
192,Type I interferon induction and signaling during SARS-CoV-2 infection WP4868,0.6161228334515509,0.9646266621206956,0.4671773069412659,"['STAT1', 'EIF2AK2', 'IRF9', 'IFNAR1']",0.9999902239788879,0,0,4
193,Gastrin signaling pathway WP4659,0.6190694422091222,0.9519865257717687,0.456513550933732,"['JAG1', 'CDKN1B', 'PTPN11', 'ELAVL1', 'RHOA', 'RHOB', 'NFKBIA', 'CDC42', 'BMP2', 'CCND1', 'KAT5', 'CCKBR', 'CDH1', 'EIF4EBP1', 'GRB2', 'RAC1', 'PRKACA', 'HRAS', 'CRK', 'MEF2D', 'BIRC2', 'MAPK3']",0.9999902239788879,0,0,22
194,G Protein Signaling Pathways WP35,0.6196461973240992,0.9493240713001797,0.4543527786916538,"['PDE1C', 'ADCY3', 'AKAP5', 'PRKCZ', 'RHOA', 'GNAI2', 'GNAO1', 'GNG10', 'GNG3', 'PRKAR1A', 'GNG4', 'GNB1', 'PDE4B', 'GNB5', 'PRKACA', 'CALM1', 'HRAS', 'CALM2']",0.9999902239788879,0,0,18
195,IL-2 signaling pathway WP49,0.6204496332470882,0.9452612720214989,0.4511834601521468,"['CCND2', 'STAT1', 'PTPN11', 'GRB2', 'MAPT', 'HRAS', 'MAPK3']",0.9999902239788879,0,0,7
196,Amino Acid metabolism WP3925,0.6333854049791845,0.9375935348697995,0.4281766409170577,"['WARS', 'PDHA1', 'MDH2', 'GSS', 'ODC1', 'GOT2', 'PYCR1', 'HNMT', 'ADH5', 'SRM', 'LDHA', 'RARS', 'SMS', 'IARS', 'BCAT1']",0.9999902239788879,0,0,15
197,IL-1 signaling pathway WP195,0.6400538975077847,0.9282585949177877,0.41419166894345166,"['NFKBIA', 'TOLLIP', 'HSPB2', 'UBE2N', 'PTPN11', 'UBE2V1', 'MAP2K7', 'SQSTM1', 'PRKCZ', 'MAPK3', 'NFKBIB']",0.9999902239788879,0,0,11
198,The influence of laminopathies on Wnt signaling WP4844,0.643568459856932,0.9206784260515604,0.4057677218009459,"['WNT10B', 'CEBPD', 'CCND1', 'FNTA', 'EMD', 'TOR1AIP1']",0.9999902239788879,0,0,6
199,15q11.2 copy number variation syndrome WP4940,0.6451285187686691,0.9646477553454298,0.4228106367955272,"['TUBGCP2', 'TUBGCP4']",0.9999902239788879,0,0,2
200,Cytosine methylation WP3585,0.6451285187686691,0.9646477553454298,0.4228106367955272,"['MECP2', 'IDH2']",0.9999902239788879,0,0,2
201,Trans-sulfuration pathway WP2333,0.6451285187686691,0.9646477553454298,0.4228106367955272,"['AHCY', 'MAT2B']",0.9999902239788879,0,0,2
202,Composition of Lipid Particles WP3601,0.6457671741717917,1.12548435171386,0.49219259799590276,['APOA1'],0.9999902239788879,0,0,1
203,Effects of nitric oxide WP1995,0.6457671741717917,1.12548435171386,0.49219259799590276,['NOS1'],0.9999902239788879,0,0,1
204,"Gamma-glutamyl cycle for the biosynthesis and degradation of glutathione, including diseases WP4518",0.6457671741717917,1.12548435171386,0.49219259799590276,['GSS'],0.9999902239788879,0,0,1
205,Hypothetical Craniofacial Development Pathway WP3655,0.6457671741717917,1.12548435171386,0.49219259799590276,['RHOA'],0.9999902239788879,0,0,1
206,Macrophage markers WP4146,0.6457671741717917,1.12548435171386,0.49219259799590276,['CD83'],0.9999902239788879,0,0,1
207,Robo4 and VEGF Signaling Pathways Crosstalk WP3943,0.6457671741717917,1.12548435171386,0.49219259799590276,['RAC1'],0.9999902239788879,0,0,1
208,Sulindac Metabolic Pathway WP2542,0.6457671741717917,1.12548435171386,0.49219259799590276,['MSRB2'],0.9999902239788879,0,0,1
209,ATM Signaling Network in Development and Disease  WP3878,0.6459693340851163,0.9206073281364587,0.4023083914076428,"['DCLRE1C', 'KAT5', 'ATMIN', 'PRKDC', 'RASGRF1', 'RNF8', 'RBBP8', 'RNF40', 'HMGN1']",0.9999902239788879,0,0,9
210,IL-9 signaling pathway WP22,0.65262753040893,0.9207493967410461,0.39292861727443823,"['STAT1', 'GRB2', 'MAPK3']",0.9999902239788879,0,0,3
211,NAD+ metabolism WP3644,0.65262753040893,0.9207493967410461,0.39292861727443823,"['NT5E', 'PARP1', 'SIRT6']",0.9999902239788879,0,0,3
212,PI3K/AKT/mTOR - VitD3 signaling WP4141,0.65262753040893,0.9207493967410461,0.39292861727443823,"['LDHA', 'PDHA1', 'SLC2A3']",0.9999902239788879,0,0,3
213,Transcription co-factors SKI and SKIL protein partners WP4533,0.65262753040893,0.9207493967410461,0.39292861727443823,"['MECP2', 'PRMT5', 'ING2']",0.9999902239788879,0,0,3
214,Spinal Cord Injury WP2431,0.6540505265761875,0.9253929609985605,0.3928947120068775,"['SEMA6A', 'CDKN1B', 'GADD45A', 'NCAN', 'OMG', 'MIF', 'PLA2G6', 'RHOA', 'RHOB', 'CDC42', 'CCND1', 'PTPRA', 'APEX1', 'NOS1', 'RAC1', 'LTB', 'MAPK3']",0.9999902239788879,0,0,17
215,Amyotrophic lateral sclerosis (ALS) WP2447,0.655170795052701,0.9088246778602108,0.3843049866716172,"['CASP9', 'CCS', 'TOMM40', 'BAX', 'NOS1', 'RAC1', 'SOD1']",0.9999902239788879,0,0,7
216,TNF related weak inducer of apoptosis (TWEAK) Signaling Pathway WP2036,0.655170795052701,0.9088246778602108,0.3843049866716172,"['NFKBIA', 'TRAF2', 'FADD', 'RAC1', 'BIRC2', 'MAPK3', 'NFKBIB']",0.9999902239788879,0,0,7
217,Host-pathogen interaction of human coronaviruses - apoptosis WP4864,0.6615721854858733,0.9002386634844869,0.3719211602169095,"['CASP9', 'BAX', 'FADD', 'BBC3']",0.9999902239788879,0,0,4
218,Kallmann's Syndrome WP5074,0.6615721854858733,0.9002386634844869,0.3719211602169095,"['PTPN11', 'GRB2', 'ASCL1', 'FGFR1']",0.9999902239788879,0,0,4
219,Fragile X Syndrome  WP4549,0.6660607790585796,0.9270225421531336,0.37671818555951586,"['CYFIP2', 'EIF4A1', 'CLTC', 'CLTA', 'AKAP5', 'SLC6A1', 'MECP2', 'DAG1', 'AP2S1', 'EIF4EBP2', 'PRKACA', 'AP2M1', 'DUSP3', 'SLC16A1', 'PPP2R5B', 'PTPN11', 'AP2B1', 'EEF1A1', 'ALDH3A2', 'ALDH5A1', 'PRKAR1A', 'GRB2', 'PTPN5', 'TELO2', 'EIF4G1']",0.9999902239788879,0,0,25
220,Complement system WP2806,0.6756127533457618,0.8934515545088666,0.3503538193499019,"['FKBP2', 'RPS19', 'SERPING1', 'APOA1', 'CD59', 'TXN', 'CALR', 'PRKACA', 'GNAI2']",0.9999902239788879,0,0,9
221,Neurodegeneration with brain iron accumulation (NBIA) subtypes pathway WP4577,0.6756127533457618,0.8934515545088666,0.3503538193499019,"['MECP2', 'BECN1', 'MAP1LC3A', 'ATG16L1', 'WIPI1', 'WIPI2', 'PLA2G6', 'WDR45', 'GTPBP2']",0.9999902239788879,0,0,9
222,Prion disease pathway WP3995,0.6794501826954109,0.8805710577547048,0.34031549666970445,"['PDIA3', 'HSPA5', 'RFX5', 'HSP90B1', 'MAPK3', 'FGFR1']",0.9999902239788879,0,0,6
223,Tumor suppressor activity of SMARCB1 WP4204,0.6794501826954109,0.8805710577547048,0.34031549666970445,"['SMARCD1', 'RBBP4', 'H3F3B', 'H3F3A', 'DPF2', 'ARID1A']",0.9999902239788879,0,0,6
224,Thyroid stimulating hormone (TSH) signaling pathway WP2032,0.6858290679155313,0.8953585622104061,0.3376637581619554,"['CDKN1B', 'STAT1', 'ADCY3', 'TTF2', 'TTF1', 'GNAI2', 'MYL12B', 'GNAO1', 'APEX1', 'GNB1', 'HRAS', 'RALGDS', 'MAPK3']",0.9999902239788879,0,0,13
225,SARS coronavirus and innate immunity WP4912,0.7009240657416469,0.843945720250522,0.2999009395500373,"['STAT1', 'IRF9', 'IFNAR1']",0.9999902239788879,0,0,3
226,Monoamine Transport WP727,0.7032095543407283,0.8438991646778043,0.297137187667135,"['PPP2CB', 'NOS1', 'SLC6A1', 'NECTIN2']",0.9999902239788879,0,0,4
227,T-Cell Receptor and Co-stimulatory Signaling WP2583,0.7032095543407283,0.8438991646778043,0.297137187667135,"['NFKBIA', 'GSK3A', 'CALM1', 'CALM2']",0.9999902239788879,0,0,4
228,Urea cycle and associated pathways WP4595,0.7032095543407283,0.8438991646778043,0.297137187667135,"['MDH2', 'GOT2', 'PYCR1', 'NOS1']",0.9999902239788879,0,0,4
229,Amplification and Expansion of Oncogenic Pathways as Metastatic Traits WP3678,0.7041253644279998,0.8439922480620154,0.296071522018723,"['JAG1', 'VHL']",0.9999902239788879,0,0,2
230,"GPCRs, Class C Metabotropic glutamate, pheromone WP501",0.7041253644279998,0.8439922480620154,0.296071522018723,"['GABBR1', 'GRM4']",0.9999902239788879,0,0,2
231,miR-509-3p alteration of YAP1/ECM axis WP3967,0.7041253644279998,0.8439922480620154,0.296071522018723,"['EDNRA', 'SPARC']",0.9999902239788879,0,0,2
232,Simplified Depiction of MYD88 Distinct Input-Output Pathway WP3877,0.7041253644279998,0.8439922480620154,0.296071522018723,"['UBE2N', 'UBE2V1']",0.9999902239788879,0,0,2
233,Transcriptional cascade regulating adipogenesis WP4211,0.7041253644279998,0.8439922480620154,0.296071522018723,"['CEBPD', 'DDIT3']",0.9999902239788879,0,0,2
234,Oxidative Stress WP408,0.7076022375484181,0.8438525813190092,0.2918659542640261,"['NFIX', 'TXNRD2', 'TXNRD1', 'TXN2', 'SOD1']",0.9999902239788879,0,0,5
235,Sphingolipid pathway WP1422,0.7076022375484181,0.8438525813190092,0.2918659542640261,"['UGCG', 'ASAH1', 'GAL3ST1', 'SERINC1', 'KDSR']",0.9999902239788879,0,0,5
236,Metapathway biotransformation Phase I and II WP702,0.7076366383948313,0.8968629609246009,0.3101572205804712,"['GSTM3', 'GAL3ST1', 'CHST7', 'GPX4', 'GSTO1', 'NAA20', 'MGST3', 'GSTP1', 'GSS', 'AKR1A1', 'HNMT', 'NAT14', 'SULT1A1', 'GSTZ1', 'CYP4Z1', 'AKR7A2', 'CHST10', 'CYP20A1', 'CHST1', 'NAT9', 'SULT4A1']",0.9999902239788879,0,0,21
237,DNA IR-damage and cellular response via ATR WP4016,0.7233701843340669,0.8726222791028909,0.2825849170000433,"['UPF1', 'FEN1', 'PCNA', 'PARP1', 'PRKDC', 'XRCC5', 'RPA1', 'HUS1', 'RPA2', 'PML', 'MSH2', 'RBBP8', 'USP1', 'RAD17', 'ATRIP']",0.9999902239788879,0,0,15
238,Vitamin D Receptor Pathway WP2877,0.7238871487343679,0.8801417146429781,0.2843911889833567,"['CDKN2D', 'CDKN1B', 'GADD45A', 'IGFBP3', 'TPM1', 'MED9', 'G0S2', 'GXYLT2', 'ADAMTS5', 'SFRP1', 'CEACAM1', 'CCND1', 'ADGRE5', 'PNOC', 'CREG2', 'TIMP2', 'CLPTM1L', 'CD200']",0.9999902239788879,0,0,18
239,ACE Inhibitor Pathway WP554,0.7267316644554102,0.8440387481371088,0.2694154544740679,['ATP6AP2'],0.9999902239788879,0,0,1
240,Acetylcholine Synthesis WP528,0.7267316644554102,0.8440387481371088,0.2694154544740679,['PDHA1'],0.9999902239788879,0,0,1
241,EV release from cardiac cells and their functional effects WP3297,0.7267316644554102,0.8440387481371088,0.2694154544740679,['RGS16'],0.9999902239788879,0,0,1
242,Linoleic acid metabolism known to be affected by coronavirus infection WP4853,0.7267316644554102,0.8440387481371088,0.2694154544740679,['ACOT2'],0.9999902239788879,0,0,1
243,Metastatic brain tumor WP2249,0.7267316644554102,0.8440387481371088,0.2694154544740679,['CDC42'],0.9999902239788879,0,0,1
244,SARS-CoV-2 and COVID-19 Pathway WP4846,0.7267316644554102,0.8440387481371088,0.2694154544740679,['CTSL'],0.9999902239788879,0,0,1
245,TCA Cycle Nutrient Utilization and Invasiveness of Ovarian Cancer WP2868,0.7267316644554102,0.8440387481371088,0.2694154544740679,['MAPK3'],0.9999902239788879,0,0,1
246,The alternative pathway of fetal androgen synthesis WP4524,0.7267316644554102,0.8440387481371088,0.2694154544740679,['STAR'],0.9999902239788879,0,0,1
247,Vitamin D Metabolism WP1531,0.7267316644554102,0.8440387481371088,0.2694154544740679,['RXRB'],0.9999902239788879,0,0,1
248,Prader-Willi and Angelman Syndrome WP3998,0.7301976342683366,0.8436659695249478,0.2652823693087635,"['CCND2', 'CCND1', 'FEZ1', 'FEZ2', 'NDN', 'MKRN3', 'ATP10A', 'PRKCZ', 'BBS4']",0.9999902239788879,0,0,9
249,Translation inhibitors in chronically activated PDGFRA cells WP4566,0.7301976342683366,0.8436659695249478,0.2652823693087635,"['EIF4A2', 'EIF4A1', 'CSNK2A1', 'EIF4EBP1', 'MAP2K7', 'PRKACA', 'EIF4B', 'MAPK3', 'EIF4G1']",0.9999902239788879,0,0,9
250,Novel intracellular components of RIG-I-like receptor (RLR) pathway WP3865,0.7359376691775904,0.8436192468619247,0.25866197281017683,"['NFKBIA', 'OTUD5', 'NLRX1', 'TKFC', 'TRADD', 'TRIM25', 'TRAF2', 'ISG15', 'FADD', 'NFKBIB']",0.9999902239788879,0,0,10
251,IL-7 signaling pathway WP205,0.740999609878649,0.7941878422013197,0.23806191972450064,"['CDKN1B', 'CCND1', 'STAT1', 'MAPK3']",0.9999902239788879,0,0,4
252,"Oligodendrocyte specification and differentiation, leading to myelin components for CNS WP4304",0.740999609878649,0.7941878422013197,0.23806191972450064,"['BMP2', 'OMG', 'IGF1', 'ASCL1']",0.9999902239788879,0,0,4
253,Lipid Metabolism Pathway WP3965,0.7415521968022901,0.8035980730698725,0.24028363992556473,"['PRKAB2', 'PDHA1', 'PRKAR1A', 'PRKAG1', 'PRKACA']",0.9999902239788879,0,0,5
254,AGE/RAGE pathway WP2324,0.7415689543159174,0.8435724962630792,0.25221731852408275,"['CASP9', 'CDC42', 'NFKBIA', 'STAT1', 'CYCS', 'RAC1', 'PRKCZ', 'DDOST', 'RHOA', 'MAPK3', 'SOD1']",0.9999902239788879,0,0,11
255,miRNA regulation of prostate cancer signaling pathways WP3981,0.743862072267393,0.8099820895522388,0.2396734152436697,"['CASP9', 'NFKBIA', 'CDKN1B', 'CCND1', 'PDGFA', 'GRB2']",0.9999902239788879,0,0,6
256,Interactome of polycomb repressive complex 2 (PRC2)  WP2916,0.7439155586186669,0.7789579939893092,0.2304373884244481,"['SETX', 'RBBP4', 'THRAP3']",0.9999902239788879,0,0,3
257,STING pathway in Kawasaki-like disease and COVID-19 WP4961,0.7439155586186669,0.7789579939893092,0.2304373884244481,"['NFKBIA', 'NLRX1', 'NFKBIE']",0.9999902239788879,0,0,3
258,G13 Signaling Pathway WP524,0.7471302868204459,0.8145921067534313,0.23746638466578363,"['CDC42', 'CFL2', 'RAC1', 'CALM1', 'CALM2', 'RHOA', 'CIT']",0.9999902239788879,0,0,7
259,Hepatitis C and Hepatocellular Carcinoma WP3646,0.7471302868204459,0.8145921067534313,0.23746638466578363,"['CASP9', 'UCHL1', 'CCND1', 'PTPN11', 'GRB2', 'RAC1', 'MAPK3']",0.9999902239788879,0,0,7
260,NO/cGMP/PKG mediated Neuroprotection WP4008,0.7471302868204459,0.8145921067534313,0.23746638466578363,"['CASP9', 'NFKBIA', 'PRKG2', 'CYCS', 'NOS1', 'CALM1', 'CALM2']",0.9999902239788879,0,0,7
261,Alanine and aspartate metabolism WP106,0.7546973930936444,0.7501490757304711,0.21112076608157979,"['DARS', 'GOT2']",0.9999902239788879,0,0,2
262,Disorders of Folate Metabolism and Transport WP4259,0.7546973930936444,0.7501490757304711,0.21112076608157979,"['ATIC', 'MTHFD1']",0.9999902239788879,0,0,2
263,FGF23 signaling in hypophosphatemic rickets and related disorders WP4790,0.7546973930936444,0.7501490757304711,0.21112076608157979,"['CCND1', 'FAM20C']",0.9999902239788879,0,0,2
264,Ganglio Sphingolipid Metabolism WP1423,0.7546973930936444,0.7501490757304711,0.21112076608157979,"['ST8SIA3', 'ST3GAL5']",0.9999902239788879,0,0,2
265,Glutathione metabolism WP100,0.7546973930936444,0.7501490757304711,0.21112076608157979,"['GPX4', 'GSS']",0.9999902239788879,0,0,2
266,"NAD metabolism, sirtuins and aging WP3630",0.7546973930936444,0.7501490757304711,0.21112076608157979,"['PARP1', 'TFAM']",0.9999902239788879,0,0,2
267,Pathways of nucleic acid metabolism and innate immune sensing WP4705,0.7546973930936444,0.7501490757304711,0.21112076608157979,"['ADAR', 'SAMHD1']",0.9999902239788879,0,0,2
268,Modulators of TCR signaling and T cell activation WP5072,0.7550503211518622,0.8207915115593634,0.2306185144664418,"['NFKBIA', 'FIBP', 'CDKN1B', 'NDUFB10', 'DGKA', 'ELOB', 'GRB2', 'RNF7', 'MEF2D']",0.9999902239788879,0,0,9
269,SARS-CoV-2 innate immunity evasion and cell-specific immune response WP5039,0.7735617469811399,0.7873693639892505,0.2021569142310267,"['LARP1', 'STAT1', 'TRADD', 'TRIM25', 'TRAF2', 'FADD', 'IFNAR1']",0.9999902239788879,0,0,7
270,1q21.1 copy number variation syndrome WP4905,0.7750113387881143,0.75,0.1911582142811074,"['PYGO2', 'BCL9', 'PRKAB2', 'PRKAG1']",0.9999902239788879,0,0,4
271,Mammary gland development pathway - Pregnancy and lactation (Stage 3 of 4) WP2817,0.7750113387881143,0.75,0.1911582142811074,"['TTC9', 'PNCK', 'CCND1', 'TPM3']",0.9999902239788879,0,0,4
272,Physiological and pathological hypertrophy of the heart WP1528,0.7750113387881143,0.75,0.1911582142811074,"['RAC1', 'CALM1', 'CALM2', 'RHOA']",0.9999902239788879,0,0,4
273,Signal Transduction of S1P Receptor WP26,0.7750113387881143,0.75,0.1911582142811074,"['ASAH1', 'MAPK6', 'GNAI2', 'MAPK3']",0.9999902239788879,0,0,4
274,Sphingolipid Metabolism (general overview) WP4725,0.7750113387881143,0.75,0.1911582142811074,"['UGCG', 'ASAH1', 'DEGS1', 'KDSR']",0.9999902239788879,0,0,4
275,Type I collagen synthesis in the context of Osteogenesis imperfecta WP4786,0.7750113387881143,0.75,0.1911582142811074,"['MBTPS1', 'CRTAP', 'P4HB', 'PPIB']",0.9999902239788879,0,0,4
276,Apoptosis Modulation by HSP70 WP384,0.781819495958683,0.7232542286225555,0.1780155676472101,"['CASP9', 'CYCS', 'FADD']",0.9999902239788879,0,0,3
277,Constitutive Androstane Receptor Pathway WP2875,0.781819495958683,0.7232542286225555,0.1780155676472101,"['SULT1A1', 'HSP90AA1', 'DNAJC7']",0.9999902239788879,0,0,3
278,Ebstein-Barr virus LMP1 signaling WP262,0.781819495958683,0.7232542286225555,0.1780155676472101,"['NFKBIA', 'HSP90AA1', 'TRADD']",0.9999902239788879,0,0,3
279,"GPCRs, Class B Secretin-like WP334",0.781819495958683,0.7232542286225555,0.1780155676472101,"['ADCYAP1R1', 'VIPR2', 'ADGRE5']",0.9999902239788879,0,0,3
280,Imatinib and Chronic Myeloid Leukemia WP3640,0.781819495958683,0.7232542286225555,0.1780155676472101,"['CDKN1B', 'FLT1', 'GADD45A']",0.9999902239788879,0,0,3
281,Nicotine Activity on Dopaminergic Neurons WP1602,0.781819495958683,0.7232542286225555,0.1780155676472101,"['CHRNA4', 'GNB1', 'PRKACA']",0.9999902239788879,0,0,3
282,Proteoglycan biosynthesis WP4784,0.781819495958683,0.7232542286225555,0.1780155676472101,"['CANT1', 'B3GAT3', 'B4GALT7']",0.9999902239788879,0,0,3
283,Regulation of apoptosis by parathyroid hormone-related protein WP3872,0.781819495958683,0.7232542286225555,0.1780155676472101,"['GSK3A', 'BAX', 'BCL2L2']",0.9999902239788879,0,0,3
284,ncRNAs involved in Wnt signaling in hepatocellular carcinoma WP4336,0.7877658715363031,0.8096411483253588,0.19314341836757198,"['WNT10B', 'SFRP1', 'FRAT2', 'CCND2', 'CCND1', 'CSNK2A1', 'CTNNBIP1', 'CSNK2B', 'CSNK1E', 'SENP2', 'ELAVL1', 'NKD1']",0.9999902239788879,0,0,12
285,Benzo(a)pyrene metabolism WP696,0.7891948449443258,0.6751713859910581,0.15984144914683363,['AKR1A1'],0.9999902239788879,0,0,1
286,Classical pathway of steroidogenesis with glucocorticoid and mineralocorticoid metabolism WP4523,0.7891948449443258,0.6751713859910581,0.15984144914683363,['STAR'],0.9999902239788879,0,0,1
287,Development of pulmonary dendritic cells and macrophage subsets WP3892,0.7891948449443258,0.6751713859910581,0.15984144914683363,['ID2'],0.9999902239788879,0,0,1
288,Drug Induction of Bile Acid Pathway WP2289,0.7891948449443258,0.6751713859910581,0.15984144914683363,['ABCC4'],0.9999902239788879,0,0,1
289,exRNA mechanism of action and biogenesis WP2805,0.7891948449443258,0.6751713859910581,0.15984144914683363,['XPO5'],0.9999902239788879,0,0,1
290,Fluoroacetic acid toxicity WP4966,0.7891948449443258,0.6751713859910581,0.15984144914683363,['ALDH3A2'],0.9999902239788879,0,0,1
291,Irinotecan pathway WP229,0.7891948449443258,0.6751713859910581,0.15984144914683363,['CES2'],0.9999902239788879,0,0,1
292,MicroRNA for Targeting Cancer Growth and Vascularization in Glioblastoma WP3593,0.7891948449443258,0.6751713859910581,0.15984144914683363,['HIF1AN'],0.9999902239788879,0,0,1
293,mir-124 predicted interactions with cell cycle and differentiation  WP3595,0.7891948449443258,0.6751713859910581,0.15984144914683363,['CTDSP1'],0.9999902239788879,0,0,1
294,Role of Altered Glycolysation of MUC1 in Tumour Microenvironment WP4480,0.7891948449443258,0.6751713859910581,0.15984144914683363,['NFKBIA'],0.9999902239788879,0,0,1
295,Small Ligand GPCRs WP247,0.7891948449443258,0.6751713859910581,0.15984144914683363,['LPAR1'],0.9999902239788879,0,0,1
296,Tamoxifen metabolism WP691,0.7891948449443258,0.6751713859910581,0.15984144914683363,['SULT1A1'],0.9999902239788879,0,0,1
297,Chromosomal and microsatellite instability in colorectal cancer  WP4216,0.7911881839114075,0.8120949247183169,0.19020841295114735,"['RALB', 'GADD45A', 'RHOA', 'BBC3', 'CASP9', 'CCND1', 'MSH2', 'RAC3', 'CYCS', 'BAX', 'RAC1', 'RALGDS', 'MAPK3']",0.9999902239788879,0,0,13
298,Cell-type Dependent Selectivity of CCK2R Signaling WP3679,0.7976133063601909,0.6750745378652355,0.1526555351453812,"['CCKBR', 'CCK']",0.9999902239788879,0,0,2
299,Dopaminergic Neurogenesis WP2855,0.7976133063601909,0.6750745378652355,0.1526555351453812,"['SOX2', 'ASCL1']",0.9999902239788879,0,0,2
300,FOXA2 pathway WP5066,0.7976133063601909,0.6750745378652355,0.1526555351453812,"['ABCC4', 'SLC27A5']",0.9999902239788879,0,0,2
301,Galanin receptor pathway WP4970,0.7976133063601909,0.6750745378652355,0.1526555351453812,"['CDKN1B', 'VAMP2']",0.9999902239788879,0,0,2
302,Hedgehog Signaling Pathway Netpath WP47,0.7976133063601909,0.6750745378652355,0.1526555351453812,"['SAP18', 'KIF7']",0.9999902239788879,0,0,2
303,Allograft Rejection WP2328,0.7978972506629674,0.7619029272098556,0.17201897502056107,"['CASP9', 'STAT1', 'HLA-B', 'HLA-C', 'HLA-A', 'HLA-F', 'PRKCZ']",0.9999902239788879,0,0,7
304,IL-6 signaling pathway WP364,0.7978972506629674,0.7619029272098556,0.17201897502056107,"['STAT1', 'PTPN11', 'GRB2', 'RAC1', 'VIP', 'MAPK3', 'NR2F6']",0.9999902239788879,0,0,7
305,Type 2 papillary renal cell carcinoma WP4241,0.798379804403639,0.7498507462686567,0.16884452945336229,"['EGLN2', 'CUL2', 'ELOB', 'ELOC', 'VHL', 'RBX1']",0.9999902239788879,0,0,6
306,Apoptosis-related network due to altered Notch3 in ovarian cancer WP2864,0.7998313834223871,0.7785617430075154,0.1738951475687454,"['ERN1', 'BEX3', 'CDKN1B', 'HSPA5', 'SERBP1', 'RNF7', 'SQSTM1', 'TNFRSF21', 'HSPD1']",0.9999902239788879,0,0,9
307,PPAR signaling pathway WP3942,0.7998313834223871,0.7785617430075154,0.1738951475687454,"['RXRB', 'FABP5', 'ACOX1', 'FABP6', 'ILK', 'APOA1', 'ACOX3', 'SLC27A2', 'SLC27A5']",0.9999902239788879,0,0,9
308,Rett syndrome causing genes WP4312,0.7998313834223871,0.7785617430075154,0.1738951475687454,"['MECP2', 'GNAO1', 'HDAC5', 'XAB2', 'EIF2B2', 'STXBP1', 'IMPDH2', 'GABRA3', 'CRK']",0.9999902239788879,0,0,9
309,Host-pathogen interaction of human coronaviruses - interferon induction WP4880,0.800533675982628,0.7335902326365913,0.1632067185166678,"['NFKBIA', 'STAT1', 'EIF2AK2', 'IRF9', 'IFNAR1']",0.9999902239788879,0,0,5
310,Ras signaling WP4223,0.8008972951593321,0.857114465383165,0.19029874859705911,"['RAB5B', 'RAB5C', 'FLT1', 'RALB', 'RASGRF1', 'PLA2G6', 'CDC42', 'RASSF1', 'GNG10', 'GNG3', 'GNG4', 'RAC3', 'RAC1', 'PRKACA', 'RALGDS', 'HRAS', 'MAPK3', 'RALBP1', 'PLA2G4C', 'PTPN11', 'RHOA', 'MRAS', 'GNB1', 'GNB4', 'CALM3', 'GRB2', 'GNB5', 'CALM1', 'CALM2', 'FGFR1']",0.9999902239788879,0,0,30
311,Cell migration and invasion through p75NTR WP4561,0.80539173167998,0.7104635096093456,0.15376312843307333,"['ARF1', 'EFNB3', 'RAC1', 'RHOA']",0.9999902239788879,0,0,4
312,Effect of progerin on genes involved in Hutchinson-Gilford progeria syndrome WP4320,0.80539173167998,0.7104635096093456,0.15376312843307333,"['CBX5', 'RBBP4', 'H3F3B', 'H3F3A']",0.9999902239788879,0,0,4
313,MTHFR deficiency WP4288,0.80539173167998,0.7104635096093456,0.15376312843307333,"['CASP9', 'EHMT2', 'CYCS', 'HNMT']",0.9999902239788879,0,0,4
314,Sphingolipid Metabolism (integrated pathway) WP4726,0.80539173167998,0.7104635096093456,0.15376312843307333,"['UGCG', 'ASAH1', 'DEGS1', 'KDSR']",0.9999902239788879,0,0,4
315,Eicosanoid metabolism via cyclooxygenases (COX) WP4719,0.8149587743779217,0.674977631971369,0.13811240476337244,"['ACOX1', 'ACOX3', 'PLA2G6']",0.9999902239788879,0,0,3
316,"Relationship between inflammation, COX-2 and EGFR WP4483",0.8149587743779217,0.674977631971369,0.13811240476337244,"['PTGES2', 'HRAS', 'MAPK3']",0.9999902239788879,0,0,3
317,T-Cell antigen Receptor (TCR) pathway during Staphylococcus aureus infection WP3863,0.819564773875627,0.7497013142174432,0.1491769493486923,"['NFKBIA', 'CHP1', 'AHSA1', 'GRB2', 'MAP2K7', 'CALM1', 'CALM2', 'MAPK3']",0.9999902239788879,0,0,8
318,22q11.2 copy number variation syndrome WP4657,0.8200429282392967,0.8074442461899278,0.1601957988033792,"['RANBP1', 'CBX5', 'TXNRD2', 'EMC10', 'RBX1', 'CDC42', 'MRPL40', 'XPO1', 'HIRIP3', 'RELN', 'POLR2A', 'THAP7', 'HIST1H4C', 'KPNB1', 'RAN', 'FGFR1', 'DGCR2']",0.9999902239788879,0,0,17
319,IL-5 signaling pathway WP127,0.8220520209817067,0.7230063965884861,0.14167426026700847,"['GSK3A', 'STAT1', 'PTPN11', 'GRB2', 'MAPT', 'MAPK3']",0.9999902239788879,0,0,6
320,Melatonin metabolism and effects WP3298,0.8257593634624256,0.7029618024470308,0.13458335543596242,"['SULT1A1', 'CRY2', 'CSNK1E', 'CALM1', 'CALM2']",0.9999902239788879,0,0,5
321,PDGFR-beta pathway WP3972,0.8257593634624256,0.7029618024470308,0.13458335543596242,"['STAT1', 'EIF2AK2', 'GRB2', 'HRAS', 'MAPK3']",0.9999902239788879,0,0,5
322,Cell cycle WP179,0.8257721945017186,0.8109611073388893,0.15524742390383064,"['YWHAE', 'CDKN2D', 'CDKN1B', 'PCNA', 'PRKDC', 'GADD45A', 'YWHAB', 'RBX1', 'ANAPC11', 'CCND2', 'ORC6', 'CCND1', 'CCNE2', 'YWHAQ', 'ORC3', 'MCM4', 'MCM6', 'SKP1', 'YWHAH']",0.9999902239788879,0,0,19
323,FGFR3 signaling in chondrocyte proliferation and terminal differentiation WP4767,0.8323429269374326,0.6748806682577566,0.12384785845672919,"['BMP2', 'THRA', 'STAT1', 'MAPK3']",0.9999902239788879,0,0,4
324,Major receptors targeted by epinephrine and norepinephrine WP4589,0.8337304519297025,0.6136499159754973,0.11158924751072156,"['ADCY3', 'ADRA2A']",0.9999902239788879,0,0,2
325,Matrix Metalloproteinases WP129,0.8337304519297025,0.6136499159754973,0.11158924751072156,"['MMP28', 'TIMP2']",0.9999902239788879,0,0,2
326,miRNAs involved in DNA damage response WP1545,0.8337304519297025,0.6136499159754973,0.11158924751072156,"['CDKN1B', 'CCND1']",0.9999902239788879,0,0,2
327,Phytochemical activity on NRF2 transcriptional activation WP3,0.8337304519297025,0.6136499159754973,0.11158924751072156,"['AIMP2', 'KEAP1']",0.9999902239788879,0,0,2
328,Tryptophan catabolism leading to NAD+ production WP4210,0.8337304519297025,0.6136499159754973,0.11158924751072156,"['QPRT', 'KMO']",0.9999902239788879,0,0,2
329,Aspirin and miRNAs WP4707,0.837383497655625,0.5625931445603577,0.09984516753968131,['ABCC4'],0.9999902239788879,0,0,1
330,DDX1 as a regulatory component of the Drosha microprocessor WP2942,0.837383497655625,0.5625931445603577,0.09984516753968131,['DDX1'],0.9999902239788879,0,0,1
331,Glial Cell Differentiation WP2276,0.837383497655625,0.5625931445603577,0.09984516753968131,['TPPP'],0.9999902239788879,0,0,1
332,Ketogenesis and Ketolysis WP4742,0.837383497655625,0.5625931445603577,0.09984516753968131,['SLC16A1'],0.9999902239788879,0,0,1
333,LDLRAD4 and what we know about it WP4904,0.837383497655625,0.5625931445603577,0.09984516753968131,['ATG16L1'],0.9999902239788879,0,0,1
334,Liver X receptor pathway WP2874,0.837383497655625,0.5625931445603577,0.09984516753968131,['ABCG8'],0.9999902239788879,0,0,1
335,Mevalonate pathway WP3963,0.837383497655625,0.5625931445603577,0.09984516753968131,['PMVK'],0.9999902239788879,0,0,1
336,Supression of HMGB1 mediated inflammation by THBD WP4479,0.837383497655625,0.5625931445603577,0.09984516753968131,['NFKBIA'],0.9999902239788879,0,0,1
337,RANKL/RANK signaling pathway WP2018,0.8388873684649968,0.7293745358261488,0.1281356625349332,"['CDC42', 'NFKBIA', 'STAT1', 'TRAF2', 'RAC1', 'MAP2K7', 'SQSTM1', 'MAPK3']",0.9999902239788879,0,0,8
338,Sterol regulatory element-binding proteins (SREBP) signaling WP1982,0.8396591054442916,0.7636092804911077,0.13344782055779553,"['MBTPS1', 'GSK3A', 'SEC13', 'PRKAB2', 'RBP4', 'SAR1A', 'NR1H2', 'PRKAG1', 'PRKACA', 'SEC23B', 'KPNB1', 'SEC31A']",0.9999902239788879,0,0,12
339,IL-3 signaling pathway WP286,0.8405105447646265,0.715600314883683,0.12433253515586137,"['YWHAQ', 'YWHAB', 'PTPN11', 'GRB2', 'PRKACA', 'HRAS', 'MAPK3']",0.9999902239788879,0,0,7
340,Splicing factor NOVA regulated synaptic proteins WP4148,0.8405105447646265,0.715600314883683,0.12433253515586137,"['CADM3', 'DAB1', 'EPB41L1', 'APLP2', 'CLSTN1', 'MAP4', 'PRKCZ']",0.9999902239788879,0,0,7
341,Metabolism of Spingolipids in ER and Golgi apparatus WP4142,0.8437187049982346,0.6327356099015806,0.10752463950310513,"['B3GALNT1', 'UGCG', 'KDSR']",0.9999902239788879,0,0,3
342,Mitochondrial Gene Expression WP391,0.8437187049982346,0.6327356099015806,0.10752463950310513,"['TFAM', 'TFB2M', 'HCFC1']",0.9999902239788879,0,0,3
343,NAD+ biosynthetic pathways WP3645,0.8437187049982346,0.6327356099015806,0.10752463950310513,"['PARP1', 'QPRT', 'SIRT6']",0.9999902239788879,0,0,3
344,Photodynamic therapy-induced NFE2L2 (NRF2) survival signaling WP3612,0.8437187049982346,0.6327356099015806,0.10752463950310513,"['ABCC4', 'GSTP1', 'KEAP1']",0.9999902239788879,0,0,3
345,Serotonin Receptor 2 and ELK-SRF/GATA4 signaling WP732,0.8437187049982346,0.6327356099015806,0.10752463950310513,"['RASGRF1', 'HRAS', 'MAPK3']",0.9999902239788879,0,0,3
346,Triacylglyceride synthesis WP325,0.8437187049982346,0.6327356099015806,0.10752463950310513,"['AGPAT5', 'DGAT2', 'AGPAT1']",0.9999902239788879,0,0,3
347,Lung fibrosis WP3624,0.8483315449155895,0.674783646672635,0.11099094249916863,"['MECP2', 'PDGFA', 'ATP11A', 'IGF1', 'FGF1']",0.9999902239788879,0,0,5
348,Endometrial cancer WP4155,0.854304209609079,0.741949177877429,0.11683320215752534,"['CASP9', 'CCND1', 'CDH1', 'GADD45A', 'ILK', 'BAX', 'GRB2', 'FGF1', 'HRAS', 'MAPK3', 'FGFR1']",0.9999902239788879,0,0,11
349,Notch Signaling Pathway Netpath WP61,0.855113909447816,0.7227581202782876,0.11312652849378335,"['NUMBL', 'JAG1', 'CCND1', 'PSEN2', 'CIR1', 'MAPT', 'DLL1', 'SKP1', 'DLL3']",0.9999902239788879,0,0,9
350,Notch Signaling WP268,0.8627265697628134,0.6746865671641791,0.09962251491943801,"['NUMBL', 'JAG1', 'PSEN2', 'DTX4', 'DLL1', 'DLL3']",0.9999902239788879,0,0,6
351,Genes related to primary cilium development (based on CRISPR) WP4536,0.8629993403505997,0.781083491086634,0.11508589780996863,"['MKKS', 'DYNLT1', 'ARL3', 'FBF1', 'DYNLL1', 'TXNDC15', 'HSPB11', 'DYNC2LI1', 'IFT20', 'TMEM17', 'IFT43', 'KIF3B', 'TCTN3', 'TCTEX1D2', 'TMEM107', 'TCTN1', 'CEP83', 'CLUAP1', 'BBS4']",0.9999902239788879,0,0,19
352,ERK Pathway in Huntington's Disease WP3853,0.8639142037900817,0.5624627310673822,0.08227806988902737,"['MAP2K7', 'HRAS']",0.9999902239788879,0,0,2
353,Fatty acid transporters WP5061,0.8639142037900817,0.5624627310673822,0.08227806988902737,"['FABP5', 'FABP6']",0.9999902239788879,0,0,2
354,GDNF/RET signaling axis WP4830,0.8639142037900817,0.5624627310673822,0.08227806988902737,"['SOX11', 'HSPB11']",0.9999902239788879,0,0,2
355,Hypertrophy Model WP516,0.8639142037900817,0.5624627310673822,0.08227806988902737,"['WDR1', 'EIF4EBP1']",0.9999902239788879,0,0,2
356,TGF-B Signaling in Thyroid Cells for Epithelial-Mesenchymal Transition WP3859,0.8639142037900817,0.5624627310673822,0.08227806988902737,"['CDH1', 'MAPK3']",0.9999902239788879,0,0,2
357,Type II diabetes mellitus WP1584,0.8639142037900817,0.5624627310673822,0.08227806988902737,"['SURF1', 'PRKCZ']",0.9999902239788879,0,0,2
358,Vitamin A and carotenoid metabolism WP716,0.8684217870484495,0.6487730413424236,0.09152744259936609,"['RXRB', 'SULT1A1', 'ABCG8', 'RBP4', 'CRABP1']",0.9999902239788879,0,0,5
359,Follicle Stimulating Hormone (FSH) signaling pathway WP2035,0.8685143823160083,0.5954632374870616,0.08394312753942847,"['EIF4EBP1', 'PRKACA', 'MAPK3']",0.9999902239788879,0,0,3
360,Endochondral Ossification with Skeletal Dysplasias WP4808,0.8725945709299411,0.6918481757191435,0.09428800284316678,"['ADAMTS5', 'THRA', 'STAT1', 'IGF1', 'PRKACA', 'CALM1', 'CALM2', 'FGFR1']",0.9999902239788879,0,0,8
361,Endochondral Ossification WP474,0.8725945709299411,0.6918481757191435,0.09428800284316678,"['ADAMTS5', 'THRA', 'STAT1', 'IGF1', 'PRKACA', 'CALM1', 'CALM2', 'FGFR1']",0.9999902239788879,0,0,8
362,Autosomal recessive Osteopetrosis pathways WP4788,0.874558983135157,0.4821801149670002,0.06462927158493324,['OSTM1'],0.9999902239788879,0,0,1
363,Folate-Alcohol and Cancer Pathway Hypotheses WP1589,0.874558983135157,0.4821801149670002,0.06462927158493324,['ADH5'],0.9999902239788879,0,0,1
364,Mammary gland development pathway - Puberty (Stage 2 of 4) WP2814,0.874558983135157,0.4821801149670002,0.06462927158493324,['CCND1'],0.9999902239788879,0,0,1
365,Nephrogenesis WP5052,0.874558983135157,0.4821801149670002,0.06462927158493324,['JAG1'],0.9999902239788879,0,0,1
366,Selective expression of chemokine receptors during T-cell polarization WP4494,0.874558983135157,0.4821801149670002,0.06462927158493324,['IFNGR2'],0.9999902239788879,0,0,1
367,TFs regulate miRNAs related to cardiac hypertrophy WP1559,0.874558983135157,0.4821801149670002,0.06462927158493324,['RASGRF1'],0.9999902239788879,0,0,1
368,Valproic acid pathway WP3871,0.874558983135157,0.4821801149670002,0.06462927158493324,['HSD17B10'],0.9999902239788879,0,0,1
369,White fat cell differentiation WP4149,0.876930385542297,0.6134193968322846,0.08055893871128574,"['WNT10B', 'TLE3', 'CEBPD', 'DDIT3']",0.9999902239788879,0,0,4
370,Melanoma WP4685,0.8818531965403847,0.7132861906404507,0.08968124496871195,"['CCND1', 'CDH1', 'GADD45A', 'BAX', 'CALM3', 'GRB2', 'RAC1', 'CALM1', 'HRAS', 'CALM2', 'MAPK3']",0.9999902239788879,0,0,11
371,mBDNF and proBDNF regulation of GABA neurotransmission WP4829,0.8862143302407531,0.6246891475181537,0.07546023131816605,"['GABRA6', 'GABRA3', 'AP2B1', 'AP2A2', 'RHOA']",0.9999902239788879,0,0,5
372,Eicosanoid metabolism via lipooxygenases (LOX) WP4721,0.8889895413829705,0.5191504976835924,0.061088339391260786,"['ACOX1', 'ACOX3']",0.9999902239788879,0,0,2
373,Eicosanoid Synthesis WP167,0.8889895413829705,0.5191504976835924,0.061088339391260786,"['PTGES2', 'PLA2G6']",0.9999902239788879,0,0,2
374,PPAR-alpha pathway WP2878,0.8889895413829705,0.5191504976835924,0.061088339391260786,"['CCND1', 'APOA1']",0.9999902239788879,0,0,2
375,NRF2-ARE regulation WP4357,0.8897667893500102,0.5623322397852669,0.06567809162727709,"['AIMP2', 'KEAP1', 'RBX1']",0.9999902239788879,0,0,3
376,Envelope proteins and their potential roles in EDMD physiopathology WP4535,0.8906091802083143,0.6557927739623768,0.07597331628687297,"['ADCY3', 'BANF1', 'GRB2', 'HRAS', 'EMD', 'RHOA', 'MAPK3']",0.9999902239788879,0,0,7
377,Thyroid hormones production and their peripheral downstream signaling effects WP4746,0.8923632276718365,0.7184574569813116,0.08181938891191726,"['THRA', 'ADCY3', 'SIRT6', 'TTF2', 'TTF1', 'CASP9', 'CREB3', 'PRKG2', 'GRB2', 'PRKACA', 'HRAS', 'MGLL', 'FGFR1']",0.9999902239788879,0,0,13
378,LncRNA involvement in canonical Wnt signaling and colorectal cancer WP4258,0.8929642175866579,0.7097708385797028,0.08035228276590646,"['WNT10B', 'SFRP1', 'CCND2', 'FRAT2', 'HNRNPK', 'CCND1', 'CSNK2A1', 'CTNNBIP1', 'CSNK2B', 'CSNK1E', 'SENP2', 'NKD1']",0.9999902239788879,0,0,12
379,Cardiac Progenitor Differentiation WP2406,0.8950914134755121,0.5866971049081664,0.06502330452366491,"['SOX2', 'MESP1', 'THY1', 'IGF1']",0.9999902239788879,0,0,4
380,IL17 signaling pathway WP2112,0.8950914134755121,0.5866971049081664,0.06502330452366491,"['CEBPD', 'IL17RE', 'MAPK3', 'NFKBIB']",0.9999902239788879,0,0,4
381,Oxidation by Cytochrome P450 WP43,0.8950914134755121,0.5866971049081664,0.06502330452366491,"['CYP4Z1', 'CYB5R1', 'CYB5R3', 'CYP20A1']",0.9999902239788879,0,0,4
382,Aryl Hydrocarbon Receptor Netpath WP2586,0.8953755143692304,0.6324067164179105,0.06988858136801196,"['HSP90AA1', 'CDKN1B', 'CDC37', 'AIP', 'NCOA7', 'HRAS']",0.9999902239788879,0,0,6
383,Integrated Cancer Pathway WP1971,0.8953755143692304,0.6324067164179105,0.06988858136801196,"['CASP9', 'CDKN1B', 'MSH2', 'STAT1', 'BAX', 'BBC3']",0.9999902239788879,0,0,6
384,Primary focal segmental glomerulosclerosis (FSGS) WP2572,0.8954186775597317,0.6881198384912841,0.07601238309035689,"['SCARB2', 'CDKN1B', 'PCNA', 'JAG1', 'YWHAQ', 'MME', 'CTSL', 'DAG1', 'FAT1', 'ILK']",0.9999902239788879,0,0,10
385,Thymic Stromal LymphoPoietin (TSLP) Signaling Pathway WP2203,0.9018990259462636,0.6023255318241889,0.062191743350393666,"['NFKBIA', 'STAT1', 'EIF4EBP1', 'PTPN11', 'MAPK3']",0.9999902239788879,0,0,5
386,Corticotropin-releasing hormone signaling pathway WP2355,0.9028617589169521,0.706806712147675,0.07222562924762951,"['HSP90AA1', 'PARP1', 'RHOA', 'GNAI2', 'CASP9', 'ERN1', 'NFKBIA', 'GNAO1', 'STAR', 'GNB1', 'CRH', 'GNB5', 'MAPK3']",0.9999902239788879,0,0,13
387,Biotin Metabolism (including IEMs) WP5031,0.9032376973934959,0.4218703427719821,0.04293354626236481,['PCCB'],0.9999902239788879,0,0,1
388,Cytokines and Inflammatory Response WP530,0.9032376973934959,0.4218703427719821,0.04293354626236481,['PDGFA'],0.9999902239788879,0,0,1
389,EDA signaling in hair follicle development WP3930,0.9032376973934959,0.4218703427719821,0.04293354626236481,['LTB'],0.9999902239788879,0,0,1
390,Estrogen Receptor Pathway WP2881,0.9032376973934959,0.4218703427719821,0.04293354626236481,['ACOX1'],0.9999902239788879,0,0,1
391,Farnesoid X receptor pathway WP2879,0.9032376973934959,0.4218703427719821,0.04293354626236481,['SLC27A5'],0.9999902239788879,0,0,1
392,"Metabolic pathway of LDL, HDL and TG, including diseases WP4522",0.9032376973934959,0.4218703427719821,0.04293354626236481,['APOA1'],0.9999902239788879,0,0,1
393,EPO Receptor Signaling WP581,0.9078860163536024,0.5326887155257664,0.05147714158183234,"['STAT1', 'GRB2', 'MAPK3']",0.9999902239788879,0,0,3
394,Wnt/beta-catenin signaling pathway in leukemia WP3658,0.9078860163536024,0.5326887155257664,0.05147714158183234,"['BCL9', 'CCND1', 'PML']",0.9999902239788879,0,0,3
395,BMP Signaling Pathway in Eyelid Development WP3927,0.90971432865685,0.4820257262117727,0.045611517228702186,"['SFRP1', 'MAPK3']",0.9999902239788879,0,0,2
396,Globo Sphingolipid Metabolism WP1424,0.90971432865685,0.4820257262117727,0.045611517228702186,"['B3GALNT1', 'ST6GALNAC4']",0.9999902239788879,0,0,2
397,Simplified Interaction Map Between LOXL4 and Oxidative Stress Pathway WP3670,0.90971432865685,0.4820257262117727,0.045611517228702186,"['BMP2', 'CDC37']",0.9999902239788879,0,0,2
398,Peptide GPCRs WP24,0.910850989859264,0.5622016706443914,0.05249612226369382,"['EDNRA', 'CCKBR', 'NMBR', 'SSTR2']",0.9999902239788879,0,0,4
399,Zinc homeostasis WP3529,0.910850989859264,0.5622016706443914,0.05249612226369382,"['SLC30A9', 'SLC39A9', 'SLC39A7', 'SLC39A1']",0.9999902239788879,0,0,4
400,Joubert Syndrome WP4656,0.9136067873243798,0.6855891655178007,0.06194641652331111,"['TMEM17', 'KAT5', 'PARP1', 'TCTN3', 'TMEM138', 'CETN2', 'ARL3', 'TCTN1', 'CEP41', 'BBS4', 'RHOA', 'ATF4']",0.9999902239788879,0,0,12
401,Signaling of Hepatocyte Growth Factor Receptor WP313,0.9156657101483859,0.5815042344539458,0.051232806139631805,"['PTPN11', 'GRB2', 'HRAS', 'CRK', 'MAPK3']",0.9999902239788879,0,0,5
402,Energy Metabolism WP1541,0.9160535861595903,0.6211673555342522,0.054464212042489024,"['PRKAB2', 'MYBBP1A', 'PRMT1', 'PRKAG1', 'TFAM', 'TFB2M', 'MEF2D']",0.9999902239788879,0,0,7
403,One-carbon metabolism and related pathways WP3940,0.9211401632095527,0.595100965759438,0.04888341934162079,"['DMGDH', 'GPX4', 'GSS', 'BCAT1', 'CDO1', 'SOD1']",0.9999902239788879,0,0,6
404,Cannabinoid receptor signaling WP3869,0.9232601050107042,0.506009543692216,0.04040196782414931,"['PRKAR1A', 'PRKACA', 'MAPK3']",0.9999902239788879,0,0,3
405,Sleep regulation WP3591,0.9232601050107042,0.506009543692216,0.04040196782414931,"['AHCY', 'STAR', 'CRH']",0.9999902239788879,0,0,3
406,Differentiation Pathway WP2848,0.9244656039993718,0.5396658711217184,0.04238505197172347,"['NT5E', 'PDGFA', 'IGF1', 'FGF1']",0.9999902239788879,0,0,4
407,Initiation of transcription and translation elongation at the HIV-1 LTR WP3414,0.9244656039993718,0.5396658711217184,0.04238505197172347,"['NFKBIA', 'HDAC5', 'SUPT4H1', 'SUPT5H']",0.9999902239788879,0,0,4
408,Nuclear receptors WP170,0.9244656039993718,0.5396658711217184,0.04238505197172347,"['RXRB', 'THRA', 'NR1H2', 'NR2F6']",0.9999902239788879,0,0,4
409,Cancer immunotherapy by CTLA4 blockade WP4582,0.9253611984416826,0.37496274217585696,0.029086284701088063,['PTPN11'],0.9999902239788879,0,0,1
410,Ethanol metabolism resulting in production of ROS by CYP2E1 WP4269,0.9253611984416826,0.37496274217585696,0.029086284701088063,['MAFF'],0.9999902239788879,0,0,1
411,Mevalonate arm of cholesterol biosynthesis pathway WP4190,0.9253611984416826,0.37496274217585696,0.029086284701088063,['PMVK'],0.9999902239788879,0,0,1
412,MFAP5-mediated ovarian cancer cell motility and invasiveness WP3301,0.9253611984416826,0.37496274217585696,0.029086284701088063,['MAPK3'],0.9999902239788879,0,0,1
413,Osteopontin Signaling WP1434,0.9253611984416826,0.37496274217585696,0.029086284701088063,['MAPK3'],0.9999902239788879,0,0,1
414,TCA cycle in senescence WP5050,0.9253611984416826,0.37496274217585696,0.029086284701088063,['PDHA1'],0.9999902239788879,0,0,1
415,"4-hydroxytamoxifen, Dexamethasone, and Retinoic Acids Regulation of p27 Expression WP3879",0.9267669067203634,0.44985092426952894,0.03421259965773283,"['EIF4EBP1', 'MAPK3']",0.9999902239788879,0,0,2
416,Netrin-UNC5B signaling pathway WP4747,0.9276998625589568,0.5620710235750522,0.04218175673900173,"['NTN4', 'PTPN11', 'RAC1', 'RHOA', 'MAPK3']",0.9999902239788879,0,0,5
417,Pancreatic adenocarcinoma pathway WP4263,0.9282813321397443,0.6837353316160591,0.05088387909862881,"['RALBP1', 'RALB', 'STAT1', 'GADD45A', 'PEBP1', 'RHOA', 'CASP9', 'CDC42', 'CCND1', 'RAC3', 'BAX', 'RAC1', 'RALGDS', 'MAPK3']",0.9999902239788879,0,0,14
418,Prolactin Signaling Pathway WP2037,0.9325613288516654,0.6504287624891826,0.045413171275778076,"['NFKBIA', 'STAT1', 'EIF4EBP1', 'PTPN11', 'GRB2', 'RAC1', 'PPIB', 'CTSD', 'HRAS', 'MAPK3', 'NFKBIB']",0.9999902239788879,0,0,11
419,Neural Crest Differentiation WP2064,0.9347348170275569,0.6359607078009225,0.04292251960931291,"['HDAC5', 'CDH1', 'MPZ', 'HDAC11', 'WNT8A', 'ASCL1', 'DLL1', 'FGFR1', 'RHOB', 'DLL3']",0.9999902239788879,0,0,10
420,Monoamine GPCRs WP58,0.9362482202045302,0.4818712453666226,0.03174309728960479,"['CHRM1', 'HTR5A', 'ADRA2A']",0.9999902239788879,0,0,3
421,Vitamin B12 metabolism WP1533,0.9362482202045302,0.4818712453666226,0.03174309728960479,"['MMAB', 'APOA1', 'SOD1']",0.9999902239788879,0,0,3
422,B Cell Receptor Signaling Pathway WP23,0.9367415689759954,0.6637342615505942,0.04337360141574582,"['KLF11', 'GSK3A', 'CD81', 'PTPN11', 'ILF2', 'NFKBIA', 'CDC42', 'BLNK', 'GRB2', 'RAC1', 'HRAS', 'CRK', 'MEF2D']",0.9999902239788879,0,0,13
423,Hedgehog Signaling Pathway WP4249,0.9381793859776488,0.5438915682367325,0.0347079537604656,"['CCND2', 'CCND1', 'CSNK1E', 'PRKACA', 'KIF7']",0.9999902239788879,0,0,5
424,Chemokine signaling pathway WP3929,0.9386624946284958,0.7032703586494417,0.044516517914579196,"['STAT1', 'ADCY3', 'CXCL14', 'PRKCZ', 'GNAI2', 'NFKBIA', 'CDC42', 'GNG10', 'GNG3', 'GNG4', 'GNB1', 'GNB4', 'GRB2', 'GNB5', 'RAC1', 'HRAS', 'CRK', 'NFKBIB', 'MAPK3']",0.9999902239788879,0,0,19
425,Hippo-Yap signaling pathway WP4537,0.9407428584188522,0.4216979725700656,0.025759606584120694,"['RASSF1', 'YWHAQ']",0.9999902239788879,0,0,2
426,Purinergic signaling WP4900,0.9407428584188522,0.4216979725700656,0.025759606584120694,"['GNAO1', 'GNAI2']",0.9999902239788879,0,0,2
427,Photodynamic therapy-induced AP-1 survival signaling. WP3611,0.9411653398368122,0.5619402985074626,0.03407406386361583,"['HSP90AA1', 'CCND1', 'BAX', 'TRAF2', 'CFLAR', 'MAP2K7']",0.9999902239788879,0,0,6
428,Bone morphogenic protein (BMP) signaling and regulation WP1425,0.9424274903697633,0.3374366616989568,0.02000874414439096,['BMP2'],0.9999902239788879,0,0,1
429,Development and heterogeneity of the ILC family WP3893,0.9424274903697633,0.3374366616989568,0.02000874414439096,['ID2'],0.9999902239788879,0,0,1
430,Leptin Insulin Overlap WP3935,0.9424274903697633,0.3374366616989568,0.02000874414439096,['LEPR'],0.9999902239788879,0,0,1
431,MAPK and NFkB signaling pathways inhibited by Yersinia YopJ WP3849,0.9424274903697633,0.3374366616989568,0.02000874414439096,['NFKBIA'],0.9999902239788879,0,0,1
432,ncRNAs involved in STAT3 signaling in hepatocellular carcinoma WP4337,0.9424274903697633,0.3374366616989568,0.02000874414439096,['SOX4'],0.9999902239788879,0,0,1
433,Neuroinflammation WP4919,0.9424274903697633,0.3374366616989568,0.02000874414439096,['NFKBIA'],0.9999902239788879,0,0,1
434,Regulation of sister chromatid separation at the metaphase-anaphase transition WP4240,0.9424274903697633,0.3374366616989568,0.02000874414439096,['ANAPC11'],0.9999902239788879,0,0,1
435,Serotonin and anxiety-related events WP3944,0.9424274903697633,0.3374366616989568,0.02000874414439096,['CRH'],0.9999902239788879,0,0,1
436,BDNF-TrkB Signaling WP3676,0.9462164762354027,0.4996022275258552,0.027619961024559592,"['TRPC3', 'EIF4EBP1', 'GRB2', 'HRAS']",0.9999902239788879,0,0,4
437,MAPK Cascade WP422,0.9462164762354027,0.4996022275258552,0.027619961024559592,"['GRB2', 'MAP2K7', 'HRAS', 'MAPK3']",0.9999902239788879,0,0,4
438,Association Between Physico-Chemical Features and Toxicity Associated Pathways WP3680,0.9481515804967275,0.5862033141135525,0.031209988784814246,"['ACTR2', 'CDKN1B', 'TMSB4X', 'PFN4', 'GRB2', 'NOS1', 'RHOA', 'SOD1']",0.9999902239788879,0,0,8
439,Circadian rhythm related genes WP3594,0.9484272177142762,0.7270940222288975,0.038499793267581024,"['DDX5', 'AHCY', 'CHRM1', 'PRKDC', 'BHLHE41', 'HEBP1', 'DBP', 'UBC', 'PRKG2', 'RPS27A', 'SKP1', 'PRMT5', 'USP2', 'CSNK1E', 'PML', 'NR2F6', 'SETX', 'STAR', 'MYBBP1A', 'THRAP3', 'ID2', 'CRY2', 'KLF9', 'CRH', 'ATF5', 'UBA52', 'ATF4']",0.9999902239788879,0,0,27
440,Ovarian infertility WP34,0.9521574016241242,0.396857132835245,0.019455889195463306,"['CDKN1B', 'CCND2']",0.9999902239788879,0,0,2
441,Statin inhibition of cholesterol production WP430,0.9521574016241242,0.396857132835245,0.019455889195463306,"['ABCG8', 'APOA1']",0.9999902239788879,0,0,2
442,Non-small cell lung cancer WP4255,0.9529374758324205,0.6177428998505232,0.029778905094487006,"['CASP9', 'RXRB', 'RASSF1', 'CCND1', 'GADD45A', 'CRABP1', 'CYCS', 'BAX', 'GRB2', 'HRAS', 'MAPK3']",0.9999902239788879,0,0,11
443,Regulation of toll-like receptor signaling pathway WP1449,0.9536208235769875,0.6460408417566382,0.030679927923813077,"['OTUD5', 'CUEDC2', 'STAT1', 'PELI3', 'TRAFD1', 'RNF41', 'NFKBIA', 'TOLLIP', 'FADD', 'RAC1', 'MAP2K7', 'SQSTM1', 'IFNAR1', 'MAPK3']",0.9999902239788879,0,0,14
444,Small cell lung cancer WP4658,0.9536208235769875,0.6460408417566382,0.030679927923813077,"['CDKN1B', 'GADD45A', 'TRAF2', 'CKS1B', 'CASP9', 'RXRB', 'NFKBIA', 'CCND1', 'CCNE2', 'CYCS', 'BAX', 'BIRC2', 'SKP1', 'NFKBIB']",0.9999902239788879,0,0,14
445,Interleukin-11 Signaling Pathway WP2332,0.9551354546552842,0.510838013076151,0.02344854329366585,"['STAT1', 'PTPN11', 'GRB2', 'HRAS', 'MAPK3']",0.9999902239788879,0,0,5
446,Nuclear Receptors Meta-Pathway WP2882,0.9552154917889658,0.7519022798993015,0.03445089784300985,"['CDKN1B', 'HSP90AB1', 'MGST3', 'GSTP1', 'KEAP1', 'SLC2A3', 'TXN', 'SLC6A1', 'SULT1A1', 'RGS2', 'CCND1', 'SLC39A9', 'FTH1', 'PRDX1', 'PDE4B', 'SLC39A7', 'SLC39A1', 'GSTM3', 'ABCG8', 'ABCC4', 'HSP90AA1', 'PLK2', 'PTGES3', 'TXNRD1', 'AIP', 'APOA1', 'CES4A', 'PSMC5', 'DNAJC7', 'ACOX1', 'CDC37', 'MAFF', 'BLVRB', 'BAX', 'SQSTM1', 'CES2', 'SLC27A5', 'BIRC2']",0.9999902239788879,0,0,38
447,ID signaling pathway WP53,0.9555923308278398,0.3067335049451294,0.013933028701836313,['ID2'],0.9999902239788879,0,0,1
448,IL1 and megakaryocytes in obesity WP2865,0.9555923308278398,0.3067335049451294,0.013933028701836313,['TIMP2'],0.9999902239788879,0,0,1
449,Overview of nanoparticle effects WP3287,0.9555923308278398,0.3067335049451294,0.013933028701836313,['BAX'],0.9999902239788879,0,0,1
450,Regulation of Wnt/B-catenin Signaling by Small Molecule Compounds WP3664,0.9555923308278398,0.3067335049451294,0.013933028701836313,['DKK3'],0.9999902239788879,0,0,1
451,Ethanol effects on histone modifications WP3996,0.9563396191182859,0.4398915961047213,0.01963771932700601,"['HDAC5', 'AHCY', 'EHMT2']",0.9999902239788879,0,0,3
452,Glycerophospholipid Biosynthetic Pathway WP2533,0.9563396191182859,0.4398915961047213,0.01963771932700601,"['PGS1', 'PTPMT1', 'CDIPT']",0.9999902239788879,0,0,3
453,Cardiac Hypertrophic Response WP2795,0.9584590914908907,0.5486955495218983,0.023280272675628627,"['HDAC5', 'RAC1', 'IGF1', 'MAP2K7', 'CALM1', 'CALM2', 'MAPK3']",0.9999902239788879,0,0,7
454,Kit receptor signaling pathway WP304,0.9584590914908907,0.5486955495218983,0.023280272675628627,"['STAT1', 'PTPN11', 'GRB2', 'MAPT', 'HRAS', 'CRK', 'MAPK3']",0.9999902239788879,0,0,7
455,"Non-genomic actions of 1,25 dihydroxyvitamin D3 WP4341",0.9584590914908907,0.5486955495218983,0.023280272675628627,"['RXRB', 'IFI27L2', 'STAT1', 'ISG15', 'HRAS', 'PRKCZ', 'MAPK3']",0.9999902239788879,0,0,7
456,MET in type 1 papillary renal cell carcinoma WP4205,0.9606809630526064,0.5616786140979689,0.02253056339706497,"['CDC42', 'RPL11', 'PTPN11', 'GRB2', 'RAC1', 'HRAS', 'CRK', 'MAPK3']",0.9999902239788879,0,0,8
457,Brain-derived neurotrophic factor (BDNF) signaling pathway WP2380,0.9609224884132572,0.6912396596802537,0.027553870765449715,"['RAB3A', 'CSNK2A1', 'STAT1', 'RASGRF1', 'PTPN11', 'YBX1', 'EIF2S2', 'EEF2', 'EIF2S1', 'NFKBIA', 'CDC42', 'BMP2', 'MARCKS', 'DPYSL2', 'EIF4EBP1', 'RACK1', 'GRB2', 'RAC1', 'MAPT', 'SQSTM1', 'HRAS', 'SH2B1', 'MAPK3']",0.9999902239788879,0,0,23
458,Common Pathways Underlying Drug Addiction WP2636,0.9619133142713204,0.4957694805764741,0.01925119608526583,"['PRKACA', 'CALM1', 'CALM2', 'ACTG1', 'MAPK3']",0.9999902239788879,0,0,5
459,Toll-like Receptor Signaling Pathway WP75,0.963018783116434,0.5721936287635787,0.021561607785277,"['NFKBIA', 'STAT1', 'TOLLIP', 'FADD', 'RAC1', 'MAP2K7', 'IFNAR1', 'NFKBIB', 'MAPK3']",0.9999902239788879,0,0,9
460,Complement and Coagulation Cascades WP558,0.9639955952453048,0.4215254995526394,0.015456730386606603,"['CLTC', 'SERPING1', 'CLU']",0.9999902239788879,0,0,3
461,Overview of leukocyte-intrinsic Hippo pathway functions WP4542,0.9639955952453048,0.4215254995526394,0.015456730386606603,"['YWHAQ', 'RAC1', 'RHOA']",0.9999902239788879,0,0,3
462,Omega-9 FA synthesis WP4724,0.9657474055732721,0.28114754098360656,0.009798825089884444,['ACOT2'],0.9999902239788879,0,0,1
463,Pathways in clear cell renal cell carcinoma WP4018,0.9676805432515478,0.5881699765107837,0.019323303206613157,"['LDHA', 'FLT1', 'BHLHE41', 'PGK1', 'VHL', 'ENO2', 'ALDOA', 'GAPDH', 'SQSTM1', 'PFKM', 'KCNJ2']",0.9999902239788879,0,0,11
464,Bladder cancer WP2828,0.9682721326816648,0.4495226730310263,0.014493556060150717,"['RASSF1', 'CCND1', 'CDH1', 'HRAS']",0.9999902239788879,0,0,4
465,Angiogenesis WP1539,0.9689966573514965,0.35501992907133667,0.011181039070955799,"['FLT1', 'TIMP2']",0.9999902239788879,0,0,2
466,Gastric Cancer Network 1 WP2361,0.9689966573514965,0.35501992907133667,0.011181039070955799,"['H3F3A', 'MCM4']",0.9999902239788879,0,0,2
467,Glycerolipids and Glycerophospholipids WP4722,0.9689966573514965,0.35501992907133667,0.011181039070955799,"['DGAT2', 'CDIPT']",0.9999902239788879,0,0,2
468,Heart Development WP1591,0.9689966573514965,0.35501992907133667,0.011181039070955799,"['BMP2', 'PTPN11']",0.9999902239788879,0,0,2
469,Hypothesized Pathways in Pathogenesis of Cardiovascular Disease WP3668,0.9689966573514965,0.35501992907133667,0.011181039070955799,"['MAPK3', 'ENG']",0.9999902239788879,0,0,2
470,Microglia Pathogen Phagocytosis Pathway WP3937,0.9689966573514965,0.35501992907133667,0.011181039070955799,"['RAC3', 'RAC1']",0.9999902239788879,0,0,2
471,Breast cancer pathway WP4262,0.9696520988962307,0.6526300661109514,0.020112709488456084,"['WNT10B', 'CSNK2A1', 'PARP1', 'GADD45A', 'CETN3', 'IGF1', 'FGF1', 'DLL1', 'DLL3', 'FRAT2', 'CCND1', 'CSNK2B', 'BAX', 'GRB2', 'HRAS', 'FGF22', 'SKP1', 'FGFR1', 'MAPK3']",0.9999902239788879,0,0,19
472,Neural Crest Cell Migration during Development WP4564,0.9703728997230106,0.4046286907247241,0.012169146635378285,"['ARF1', 'RAC1', 'RHOA']",0.9999902239788879,0,0,3
473,PI3K-AKT-mTOR signaling pathway and therapeutic opportunities WP3844,0.9703728997230106,0.4046286907247241,0.012169146635378285,"['CDKN1B', 'EIF4EBP1', 'HRAS']",0.9999902239788879,0,0,3
474,Regucalcin in proximal tubule epithelial kidney cells WP4838,0.9703728997230106,0.4046286907247241,0.012169146635378285,"['CASP9', 'BAX', 'NOS1']",0.9999902239788879,0,0,3
475,Factors and pathways affecting insulin-like growth factor (IGF1)-Akt signaling WP3850,0.9735072235087867,0.43498344753252755,0.011679320379543171,"['MAP1LC3A', 'EIF2B2', 'ILK', 'IGF1']",0.9999902239788879,0,0,4
476,Differentiation of white and brown adipocyte WP2895,0.9735806506795533,0.2594978791700103,0.0069479548999016455,['BMP2'],0.9999902239788879,0,0,1
477,Riboflavin and CoQ disorders WP5037,0.9735806506795533,0.2594978791700103,0.0069479548999016455,['FLAD1'],0.9999902239788879,0,0,1
478,Serotonin and anxiety WP3947,0.9735806506795533,0.2594978791700103,0.0069479548999016455,['CRH'],0.9999902239788879,0,0,1
479,AMP-activated protein kinase (AMPK) signaling WP1403,0.9744091038938366,0.528498137606297,0.013700806327325907,"['PRKAB2', 'PRKAG1', 'LEPR', 'EIF4EBP1', 'ADIPOR1', 'EEF2', 'ELAVL1', 'CAMKK2']",0.9999902239788879,0,0,8
480,Estrogen signaling pathway WP712,0.9751076643166037,0.3372391174716756,0.008500917667530404,"['GNB1', 'PRKACA']",0.9999902239788879,0,0,2
481,Osteoblast differentiation WP4787,0.9752642941861384,0.5915588037933237,0.014816639522716476,"['WNT10B', 'JAG1', 'PRKDC', 'STAT1', 'WNT8A', 'FGF1', 'PRKCZ', 'DLL1', 'DLL3', 'BMP2', 'MAPK6', 'FGFR1', 'MAPK3']",0.9999902239788879,0,0,13
482,Epithelial to mesenchymal transition in colorectal cancer WP4239,0.9761316558044966,0.6310852306770521,0.01524563610191701,"['WNT10B', 'SPARC', 'JAG1', 'PDCD6', 'EIF5A2', 'WNT8A', 'DLL1', 'DLL3', 'RBBP4', 'CDH1', 'CTDSP1', 'ID2', 'CLDN12', 'STRAP', 'GRB2', 'HRAS', 'MEF2D', 'MAPK3']",0.9999902239788879,0,0,18
483,Pathways Regulating Hippo Signaling WP4540,0.976626657701054,0.5772898154477102,0.01365338403025542,"['CDC42', 'PRKAB2', 'FLT1', 'CDH1', 'PRKAR1A', 'PRKAG1', 'RAC1', 'PRKACA', 'PRKCZ', 'RHOA', 'FGFR1', 'GNAI2']",0.9999902239788879,0,0,12
484,Glucocorticoid Receptor Pathway WP2880,0.9768509542483828,0.48140724946695096,0.011275132140943096,"['RGS2', 'HSP90AA1', 'PLK2', 'PTGES3', 'PDE4B', 'BIRC2']",0.9999902239788879,0,0,6
485,Wnt Signaling Pathway WP363,0.9768509542483828,0.48140724946695096,0.011275132140943096,"['BCL9', 'GSK3A', 'CCND1', 'RAC1', 'CSNK1E', 'RHOA']",0.9999902239788879,0,0,6
486,"GPCRs, Other WP117",0.9769945850554843,0.4554509746989604,0.010600243127103896,"['EDNRA', 'CCKBR', 'GPR61', 'SSTR2', 'CELSR2']",0.9999902239788879,0,0,5
487,EGF/EGFR signaling pathway WP437,0.977606419552824,0.6674314877557147,0.015116071056603265,"['NDUFA13', 'RALB', 'PCNA', 'STXBP1', 'PEBP1', 'NEDD8', 'PRKCZ', 'CDC42', 'STMN1', 'EIF4EBP1', 'AP2S1', 'RAC1', 'RALGDS', 'HRAS', 'MEF2D', 'AP2M1', 'RALBP1', 'IQSEC1', 'STAT1', 'PTPN11', 'AP2B1', 'EPN1', 'GRB2', 'CRK', 'PTPN5']",0.9999902239788879,0,0,25
488,Wnt signaling WP428,0.9781568123121154,0.5836195034400239,0.0128894013217194,"['WNT10B', 'CSNK2A1', 'CTNNBIP1', 'CSNK1E', 'SENP2', 'RHOA', 'NKD1', 'SFRP1', 'CCND2', 'FRAT2', 'CCND1', 'CSNK2B', 'RAC1']",0.9999902239788879,0,0,13
489,Focal Adhesion-PI3K-Akt-mTOR-signaling pathway WP3932,0.9781593158059622,0.718861072227992,0.015874409658112456,"['CDKN1B', 'CHRM1', 'FLT1', 'HSP90AB1', 'LPAR1', 'PDGFA', 'SLC2A3', 'ITGAE', 'FGF1', 'ELAVL1', 'HSP90B1', 'CASP9', 'PPP2CB', 'GNG10', 'GNG3', 'RELN', 'GNG4', 'PPP2R3C', 'EIF4EBP1', 'NOS1', 'HRAS', 'FGF22', 'EIF4B', 'MAPK3', 'RAB2A', 'HSP90AA1', 'PPP2R5B', 'PPP2R5D', 'IGF1', 'CREB3', 'RAB14', 'PIK3IP1', 'CDC37', 'GNB1', 'GNB4', 'GRB2', 'EIF4E2', 'ATF4', 'IFNAR1', 'FGFR1']",0.9999902239788879,0,0,40
490,Canonical and non-canonical TGF-B signaling WP3874,0.979622798214012,0.24094102618692784,0.0049604170332275405,['LOXL2'],0.9999902239788879,0,0,1
491,Cholesterol Biosynthesis Pathway WP197,0.979622798214012,0.24094102618692784,0.0049604170332275405,['PMVK'],0.9999902239788879,0,0,1
492,MAP3K1 role in promoting and blocking gonadal determination WP4872,0.979622798214012,0.24094102618692784,0.0049604170332275405,['RHOA'],0.9999902239788879,0,0,1
493,MAPK pathway in congenital thyroid cancer WP4928,0.979622798214012,0.24094102618692784,0.0049604170332275405,['MAPK3'],0.9999902239788879,0,0,1
494,MFAP5 effect on permeability and motility of endothelial cells via cytoskeleton rearrangement WP4560,0.979622798214012,0.24094102618692784,0.0049604170332275405,['MAPK3'],0.9999902239788879,0,0,1
495,TCA Cycle and Deficiency of Pyruvate Dehydrogenase complex (PDHc) WP2453,0.979622798214012,0.24094102618692784,0.0049604170332275405,['PDHA1'],0.9999902239788879,0,0,1
496,Thermogenesis WP4321,0.9796277452327691,0.5891457211250748,0.012126169149749086,"['SMARCD1', 'PRKAB2', 'PRKAG1', 'ADCY3', 'SIRT6', 'ARID1A', 'ACTG1', 'CREB3', 'PRKG2', 'GRB2', 'PRKACA', 'HRAS', 'MGLL', 'FGFR1']",0.9999902239788879,0,0,14
497,Kisspeptin/kisspeptin receptor system in the ovary WP4871,0.9800577319032955,0.37458991947509696,0.007545664025572175,"['STAR', 'HRAS', 'MAPK3']",0.9999902239788879,0,0,3
498,Oncostatin M Signaling Pathway WP2374,0.9804834986044577,0.4913220364287847,0.009683693527338522,"['NFKBIA', 'CDKN1B', 'STAT1', 'PTPN11', 'GRB2', 'HRAS', 'MAPK3']",0.9999902239788879,0,0,7
499,DNA damage response (only ATM dependent) WP710,0.9807391064577831,0.57588913204339,0.011200353307449545,"['WNT10B', 'CDKN1B', 'RHOA', 'BBC3', 'CDC42', 'CCND2', 'CCND1', 'CCNG2', 'RAC3', 'BAX', 'GRB2', 'RAC1', 'HRAS']",0.9999902239788879,0,0,13
500,Head and Neck Squamous Cell Carcinoma WP4674,0.9816238226222036,0.5226347835941605,0.009693368325362613,"['CCND1', 'SESN2', 'EIF4EBP1', 'FAT1', 'KEAP1', 'FADD', 'HRAS', 'BIRC2', 'FGFR1']",0.9999902239788879,0,0,9
501,Mechanoregulation and pathology of YAP/TAZ via Hippo and non-Hippo mechanisms WP4534,0.981638376358663,0.40854849208071164,0.0075713393915833125,"['YWHAQ', 'CDH1', 'LIMD1', 'ACTG1']",0.9999902239788879,0,0,4
502,Nephrotic syndrome WP4758,0.981638376358663,0.40854849208071164,0.0075713393915833125,"['SCARB2', 'YARS', 'ARHGDIA', 'WDR73']",0.9999902239788879,0,0,4
503,Neural Crest Cell Migration in Cancer WP4565,0.9836835367802154,0.36117975373865624,0.0059417835223559866,"['ARF1', 'RAC1', 'RHOA']",0.9999902239788879,0,0,3
504,IL-4 signaling pathway WP395,0.9837214363995499,0.4320179969239951,0.007090501897202642,"['NFKBIA', 'STAT1', 'PTPN11', 'GRB2', 'MAPK3']",0.9999902239788879,0,0,5
505,Glycosaminoglycan degradation WP4815,0.9842832919967812,0.22485842026825634,0.003562100284780699,['HEXB'],0.9999902239788879,0,0,1
506,Mitochondrial LC-Fatty Acid Beta-Oxidation WP368,0.9842832919967812,0.22485842026825634,0.003562100284780699,['ACADS'],0.9999902239788879,0,0,1
507,SREBF and miR33 in cholesterol and lipid homeostasis WP2011,0.9842832919967812,0.22485842026825634,0.003562100284780699,['SIRT6'],0.9999902239788879,0,0,1
508,Transcription factor regulation in adipogenesis WP3599,0.9842832919967812,0.22485842026825634,0.003562100284780699,['CEBPD'],0.9999902239788879,0,0,1
509,Integrated breast cancer pathway WP1984,0.9848965100708911,0.625115760703719,0.009513455008326859,"['GSK3A', 'GADD45A', 'STAT1', 'TRADD', 'DCAKD', 'ODC1', 'PHB', 'PML', 'CASP9', 'CDC42', 'CCND1', 'MSH2', 'CDH1', 'ZMIZ1', 'DAG1', 'BAX', 'FADD', 'RAC1', 'FAU', 'MAP3K13', 'RPP38']",0.9999902239788879,0,0,21
510,Wnt signaling pathway and pluripotency WP399,0.9854146759709672,0.5367388054851499,0.007886161338268846,"['SOX2', 'WNT10B', 'PPP2CB', 'CCND2', 'CCND1', 'CSNK1E', 'PRKCZ', 'FBXW2', 'RHOA', 'NKD1', 'PAFAH1B1']",0.9999902239788879,0,0,11
511,Structural Pathway of Interleukin 1 (IL-1) WP2637,0.986343625273913,0.4211802447030737,0.005791430850622306,"['NFKBIA', 'TOLLIP', 'MAP2K7', 'MAPK3', 'NFKBIB']",0.9999902239788879,0,0,5
512,Fatty acid beta-oxidation WP143,0.9866726703378489,0.34869442701852177,0.00467841065352598,"['GCDH', 'ECHS1', 'ACADS']",0.9999902239788879,0,0,3
513,Signal transduction through IL1R WP4496,0.9872312778328174,0.2931736278551243,0.0037675575668430317,"['NFKBIA', 'TOLLIP']",0.9999902239788879,0,0,2
514,Wnt signaling in kidney disease WP4150,0.9872312778328174,0.2931736278551243,0.0037675575668430317,"['WNT10B', 'RHOA']",0.9999902239788879,0,0,2
515,Regulation of Actin Cytoskeleton WP51,0.9874083517219051,0.6029452507901686,0.007640277962905501,"['CYFIP2', 'CHRM1', 'PDGFA', 'BRK1', 'ARPC5', 'FGF1', 'RHOA', 'ACTG1', 'CDC42', 'MRAS', 'CFL2', 'TMSB4X', 'RAC3', 'RAC1', 'MAPK6', 'CRK', 'FGF22', 'FGFR1', 'MAPK3']",0.9999902239788879,0,0,19
516,Adipogenesis WP236,0.9876598014043997,0.5608916816277678,0.0069645757965139604,"['GDF10', 'CNTFR', 'WNT10B', 'CEBPD', 'GADD45A', 'STAT1', 'MIF', 'IGF1', 'BSCL2', 'BMP2', 'DDIT3', 'NDN', 'TRIB3', 'MEF2D']",0.9999902239788879,0,0,14
517,TGF-beta Receptor Signaling WP560,0.9895478777441508,0.37440334128878283,0.00393390432291673,"['STAT1', 'HRAS', 'ENG', 'MAPK3']",0.9999902239788879,0,0,4
518,Extracellular vesicle-mediated signaling in recipient cells WP2870,0.9898055336676478,0.28093321407274896,0.0028786624651315354,"['PROM1', 'HRAS']",0.9999902239788879,0,0,2
519,Nanoparticle-mediated activation of receptor signaling WP2643,0.9898055336676478,0.28093321407274896,0.0028786624651315354,"['GRB2', 'HRAS']",0.9999902239788879,0,0,2
520,Resistin as a regulator of inflammation WP4481,0.9898055336676478,0.28093321407274896,0.0028786624651315354,"['NFKBIA', 'MAPK3']",0.9999902239788879,0,0,2
521,Hepatitis B infection WP4666,0.9898189802972205,0.5776362002777097,0.005911067201891552,"['PCNA', 'ATP6AP1', 'YWHAB', 'STAT1', 'CASP9', 'DDB1', 'CREB3', 'YWHAQ', 'CYCS', 'BAX', 'GRB2', 'FADD', 'MAP2K7', 'HRAS', 'IFNAR1', 'ATF4', 'MAPK3']",0.9999902239788879,0,0,17
522,PI3K-Akt signaling pathway WP4172,0.9898326689554839,0.6852982447502524,0.007003317280329015,"['CDKN1B', 'CHRM1', 'FLT1', 'HSP90AB1', 'LPAR1', 'PDGFA', 'FGF1', 'HSP90B1', 'CASP9', 'PPP2CB', 'GNG10', 'GNG3', 'RELN', 'CCND2', 'CCND1', 'GNG4', 'PPP2R3C', 'EIF4EBP1', 'RAC1', 'HRAS', 'FGF22', 'EIF4B', 'MAPK3', 'HSP90AA1', 'PPP2R5B', 'PPP2R5D', 'IGF1', 'CREB3', 'CCNE2', 'CDC37', 'GNB1', 'GNB4', 'GRB2', 'SGK3', 'GNB5', 'EIF4E2', 'SGK2', 'ATF4', 'IFNAR1', 'FGFR1']",0.9999902239788879,0,0,40
523,Synaptic signaling pathways associated with autism spectrum disorder WP4539,0.9904373297184723,0.40105299057850535,0.0038535923379216406,"['PRKAB2', 'PRKAG1', 'EIF4EBP1', 'HRAS', 'MAPK3']",0.9999902239788879,0,0,5
524,miRNAs involvement in the immune response in sepsis WP4329,0.9906505898107024,0.1983694222845621,0.0018633614000750896,['NFKBIA'],0.9999902239788879,0,0,1
525,Vitamin D in inflammatory diseases WP4482,0.9906505898107024,0.1983694222845621,0.0018633614000750896,['NFKBIA'],0.9999902239788879,0,0,1
526,Host-pathogen interaction of human coronaviruses - MAPK signaling WP4877,0.9911501944766861,0.32614028842731113,0.0028991254798369282,"['DDIT3', 'MAP2K7', 'MAPK3']",0.9999902239788879,0,0,3
527,Vitamin D-sensitive calcium signaling in depression WP4698,0.9911501944766861,0.32614028842731113,0.0028991254798369282,"['CHRM1', 'GPX4', 'ATP2B3']",0.9999902239788879,0,0,3
528,T-cell receptor (TCR) signaling pathway WP69,0.9911566744825191,0.4644254933465167,0.004125333654954619,"['CDC42', 'NFKBIA', 'CD83', 'PTPN11', 'GRB2', 'HRAS', 'CRK', 'MAPK3']",0.9999902239788879,0,0,8
529,Neovascularisation processes WP4331,0.9918702814817291,0.26967203339296364,0.002201317945089035,"['JAG1', 'MAPK3']",0.9999902239788879,0,0,2
530,Phosphodiesterases in neuronal function WP4222,0.9920171103257254,0.3916914770321945,0.0031393772372509004,"['PDE10A', 'PDE1C', 'PDE4B', 'ADCY3', 'NOS1']",0.9999902239788879,0,0,5
531,The Overlap Between Signal Transduction Pathways that Contribute to a Range of LMNA Laminopathies WP4879,0.9920171103257254,0.3916914770321945,0.0031393772372509004,"['WNT10B', 'BMP2', 'FNTA', 'CEBPD', 'EMD']",0.9999902239788879,0,0,5
532,Hematopoietic Stem Cell Gene Regulation by GABP alpha/beta Complex WP3657,0.9927890392529664,0.1873323397913562,0.0013557401392701905,['TERF2'],0.9999902239788879,0,0,1
533,Serotonin Receptor 4/6/7 and NR3C Signaling WP734,0.9927890392529664,0.1873323397913562,0.0013557401392701905,['MAPK3'],0.9999902239788879,0,0,1
534,Cholesterol metabolism (includes both Bloch and Kandutsch-Russell pathways) WP4718,0.992878830236208,0.3546350960934556,0.002534451602240827,"['NR1H2', 'PMVK', 'ACOT2', 'TM7SF2']",0.9999902239788879,0,0,4
535,EGFR Tyrosine Kinase Inhibitor Resistance WP4806,0.9936169258933101,0.48078729399709674,0.0030787373181098616,"['MRAS', 'CCND1', 'EIF4EBP1', 'PDGFA', 'BAX', 'GRB2', 'IGF1', 'EIF4E2', 'HRAS', 'MAPK3']",0.9999902239788879,0,0,10
536,Insulin Signaling WP481,0.9942913783181941,0.5868112091867341,0.0033594813453821128,"['CAP1', 'XBP1', 'ARF1', 'GSK3A', 'STXBP3', 'STXBP1', 'PTPN11', 'PRKCZ', 'EIF4EBP1', 'TRIB3', 'GRB2', 'SGK3', 'RAC1', 'MAP2K7', 'MAP3K13', 'MAPK6', 'HRAS', 'SGK2', 'CRK', 'PFKM', 'VAMP2', 'MAPK3']",0.9999902239788879,0,0,22
537,TGF-beta receptor signaling in skeletal dysplasias WP4816,0.9951763979055523,0.3368436754176611,0.001628731199491138,"['STAT1', 'HRAS', 'ENG', 'MAPK3']",0.9999902239788879,0,0,4
538,PKC-gamma calcium signaling pathway in ataxia WP4760,0.9957103803224766,0.16856929955290612,0.0007246535420108313,['TRPC3'],0.9999902239788879,0,0,1
539,TLR4 Signaling and Tolerance WP3851,0.9957103803224766,0.16856929955290612,0.0007246535420108313,['NFKBIA'],0.9999902239788879,0,0,1
540,Toll-like Receptor Signaling related to MyD88 WP3858,0.9957103803224766,0.16856929955290612,0.0007246535420108313,['TOLLIP'],0.9999902239788879,0,0,1
541,Arrhythmogenic Right Ventricular Cardiomyopathy WP2118,0.9957686883756208,0.3884845005740528,0.0016472865374724532,"['SGCB', 'DAG1', 'ATP2A2', 'EMD', 'CACNG3', 'ACTG1']",0.9999902239788879,0,0,6
542,Integrin-mediated Cell Adhesion WP185,0.9959487683250421,0.4609060911003938,0.0018710299074766422,"['CDC42', 'CAPN5', 'ILK', 'RAC3', 'GRB2', 'ITGAE', 'RAC1', 'MAPK6', 'HRAS', 'CRK']",0.9999902239788879,0,0,10
543,Glioblastoma signaling pathways WP2261,0.9959632660730925,0.44538128965359675,0.001801524350891579,"['CDKN1B', 'CCND2', 'CCND1', 'GRB2', 'MAP2K7', 'HRAS', 'PRKCZ', 'MAPK3', 'FGFR1']",0.9999902239788879,0,0,9
544,MicroRNAs in cardiomyocyte hypertrophy WP1544,0.9966432731723808,0.4206615890083632,0.0014144212844388064,"['HDAC5', 'RAC1', 'IGF1', 'MAP2K7', 'CALM1', 'CALM2', 'RHOA', 'MAPK3']",0.9999902239788879,0,0,8
545,Ciliopathies WP4803,0.996657358810966,0.5722972297229723,0.0019161886451472012,"['GALNT11', 'MKKS', 'DNAAF1', 'ARL3', 'PKD1L1', 'CFAP410', 'KIF7', 'POMGNT1', 'CCDC28B', 'DYNC2LI1', 'RSPH1', 'TMEM17', 'IFT43', 'TMEM138', 'TCTN3', 'TCTEX1D2', 'TMEM107', 'TCTN1', 'CEP83', 'CEP41', 'CLUAP1', 'TRIM32', 'BBS4']",0.9999902239788879,0,0,23
546,Regulatory circuits of the STAT3 signaling pathway WP4538,0.9970402605621366,0.37402985074626866,0.0011086724014431457,"['CNTFR', 'IFNGR2', 'STMN1', 'MAPK6', 'IFNAR1', 'MAPK3']",0.9999902239788879,0,0,6
547,MECP2 and Associated Rett Syndrome WP3584,0.9973073542492342,0.39263959390862946,0.001058665279907187,"['MECP2', 'PRPF38A', 'CEBPD', 'SST', 'TAP1', 'YBX1', 'IGF1']",0.9999902239788879,0,0,7
548,Development of ureteric collection system WP5053,0.9974167716841748,0.2246273106738223,0.0005810143993782218,"['CCND1', 'ILK']",0.9999902239788879,0,0,2
549,Prostaglandin Synthesis and Regulation WP98,0.9974167716841748,0.2246273106738223,0.0005810143993782218,"['ABCC4', 'EDNRA']",0.9999902239788879,0,0,2
550,Fibrin Complement Receptor 3 Signaling Pathway WP4136,0.9974479918508216,0.15321772117599242,0.0003915126575427264,['RHOA'],0.9999902239788879,0,0,1
551,"GPCRs, Class A Rhodopsin-like WP455",0.9978274316911142,0.4368076633468146,0.0009500268596776216,"['GPR173', 'EDNRA', 'CHRM1', 'CCKBR', 'GPR22', 'PRLHR', 'NMBR', 'SSTR2', 'HTR5A', 'ADRA2A']",0.9999902239788879,0,0,10
552,Disruption of postsynaptic signaling by CNV WP4875,0.9979512621346656,0.21736203281589628,0.0004457746208703286,"['RPH3A', 'MAPK3']",0.9999902239788879,0,0,2
553,ATM Signaling Pathway WP2516,0.9983762918939257,0.21055083482409065,0.0003421509491118192,"['NFKBIA', 'GADD45A']",0.9999902239788879,0,0,2
554,Hippo-Merlin Signaling Dysregulation WP4541,0.9984196273552532,0.4256735796378824,0.0006732550179942219,"['DDB1', 'FLT1', 'CCND1', 'CDH1', 'PRKAR1A', 'ITGAE', 'PRKACA', 'HRAS', 'RBX1', 'FGFR1']",0.9999902239788879,0,0,10
555,Hematopoietic Stem Cell Differentiation WP2849,0.998481426360248,0.140424739195231,0.00021340738576833967,['ZNF835'],0.9999902239788879,0,0,1
556,Genes controlling nephrogenesis WP4823,0.9988284172164302,0.13479582712369598,0.00015801705347004205,['ILK'],0.9999902239788879,0,0,1
557,ESC Pluripotency Pathways WP3931,0.9988551182269821,0.41508932722321845,0.00047550045278127483,"['WNT10B', 'ACTR2', 'PDGFA', 'GRB2', 'PTPN11', 'FGF1', 'MAPK6', 'HRAS', 'FGF22', 'FGFR1']",0.9999902239788879,0,0,10
558,Pathways affected in adenoid cystic carcinoma WP3651,0.9989968738820141,0.31159852780264596,0.000312729501367285,"['MORF4L1', 'PRKDC', 'ARID1A', 'DTX4', 'HRAS']",0.9999902239788879,0,0,5
559,TYROBP causal network in microglia WP3945,0.9993023274301387,0.12478887232985594,8.709215768708618e-05,['ABCC4'],0.9999902239788879,0,0,1
560,TGF-beta Signaling Pathway WP366,0.9994423192092374,0.43237976205637313,0.000241197149374755,"['KLF11', 'UBE2I', 'RHOA', 'PML', 'RBX1', 'CDC42', 'CCND1', 'SUMO1', 'SNIP1', 'STRAP', 'GRB2', 'RAC1', 'SKP1']",0.9999902239788879,0,0,13
561,Endoderm differentiation WP2853,0.9996018282343966,0.41132457767796116,0.00016381044784238467,"['SOX2', 'SFRP1', 'STAT1', 'TCEAL2', 'CTR9', 'NABP2', 'WNT8A', 'LEO1', 'CEBPZ', 'RTF1', 'ELAVL1', 'NME1']",0.9999902239788879,0,0,12
562,Angiopoietin Like Protein 8 Regulatory Pathway WP3915,0.9996498049882037,0.41979509422674244,0.00014703589509621596,"['CAP1', 'ABCG8', 'PRKAB2', 'GSK3A', 'THRA', 'PRKAG1', 'EIF4EBP1', 'MAP2K7', 'MAP3K13', 'MAPK6', 'HRAS', 'CRK', 'MAPK3']",0.9999902239788879,0,0,13
563,Male infertility WP4673,0.999720030436044,0.36003457253830723,0.00010081283520399845,"['NANOS1', 'GNAO1', 'MTHFD1', 'UBE2B', 'PARP1', 'XRCC5', 'MOV10L1', 'NOS1', 'CLU']",0.9999902239788879,0,0,9
564,ErbB signaling pathway WP673,0.9997495795019563,0.3403354354763093,8.523764232581195e-05,"['CDKN1B', 'CCND1', 'EIF4EBP1', 'GRB2', 'MAP2K7', 'HRAS', 'CRK', 'MAPK3']",0.9999902239788879,0,0,8
565,MAPK Signaling Pathway WP382,0.9997803369989492,0.5212139423076924,0.0001145039953629264,"['RASGRF1', 'PDGFA', 'FGF1', 'DUSP16', 'CDC42', 'STMN1', 'RAC3', 'RAC1', 'PRKACA', 'MAP2K7', 'HRAS', 'CACNG3', 'FGF22', 'MAPK3', 'HSPA8', 'DUSP3', 'GADD45A', 'PLA2G4C', 'TRAF2', 'MRAS', 'DDIT3', 'GRB2', 'MAPT', 'MAP3K13', 'CRK', 'PTPN5', 'ATF4', 'FGFR1']",0.9999902239788879,0,0,28
566,Ectoderm Differentiation WP2858,0.9997901757445148,0.3950534759358289,8.29004990370075e-05,"['SOX2', 'MECP2', 'ABCC4', 'GRAMD1B', 'ARHGEF9', 'MAFB', 'ARX', 'HMGB2', 'UBTF', 'RRBP1', 'CELSR2', 'LY6E']",0.9999902239788879,0,0,12
567,Focal Adhesion WP306,0.9998052056962746,0.46905133236068486,9.137742788885041e-05,"['FLT1', 'RASGRF1', 'PDGFA', 'ILK', 'PARVB', 'IGF1', 'RHOA', 'MYL12B', 'ACTG1', 'CDC42', 'RELN', 'CCND2', 'CCND1', 'RAC3', 'GRB2', 'RAC1', 'HRAS', 'CRK', 'BIRC2', 'MAPK3']",0.9999902239788879,0,0,20
568,Phosphoinositides metabolism WP4971,0.999988563853938,0.07645982929142392,8.744107756085892e-07,['MTMR9'],0.9999902239788879,0,0,1
569,Mesodermal commitment pathway WP2857,0.9999902239788879,0.27109807754969045,2.650273484154168e-06,"['SOX2', 'CCND1', 'PRKAR1A', 'NABP2', 'RPL38', 'PRKACA', 'DLL1', 'FGFR1']",0.9999902239788879,0,0,8
